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Abstract
Pain mitigation for surgical procedures is a topic of concern for the public,
producers, and veterinarians. The objective of this study was to determine the
efficacy of meloxicam for pain mitigation in adult lactating dairy cattle following a
right-side laparotomy with omentopexy. Twenty-four dairy cattle (mean age: 2.51
+/- 0.54 years) were enrolled. Cattle were assigned blocks based on parity, days
in milk, milk yield, and pregnancy status, and randomly allocated to groups
Meloxicam (MEL) or placebo treated control (CON). The study had two phases;
sham (day 0-14) and surgery (day 15-28). On day 0, cattle were prepared for
surgery. Injectable meloxicam (MEL) or saline placebo (CON) was administered
(dose: 0.5 mg/kg) 5 minutes before simulated surgery (restraint for 30 minutes).
On day 15, the surgical procedure was performed. Meloxicam or saline were
administered prior to surgery. A right flank laparotomy, brief abdominal
exploration, and omentopexy was performed on all animals. Blood was collected
via jugular catheter at hours 0, 2, 4, 8, 12, 24, 36, 48, 60, & 72 during both
phases for cortisol, and at hours 0, 2, 4, 8, 12, 24, 48, 72, 96, 120, 144, & 168 for
haptoglobin, PGE2, and fibrinogen. Mechanical nociceptive threshold (MNT) was
measured using an algometer and collected at hours 0, 1, 4, & 8 after sham and
hours 0, 1, 2, 4, 8, 12, 24, 36, 48, 60, & 72 after surgery. Infrared thermography
(IRT) was taken of the incision site at hours 0, 1, 4, & 8 hours after sham and 0,
2, 4, 8, 12, 24, 36, 48, 60, & 72 after surgery. PGE2 concentrations displayed a
treatment by time interaction where concentrations were higher in the CON
animals (P = 0.003). Total cortisol concentrations were significantly increased in
v

CON 4 hours post-operatively (P=0.004). Haptoglobin was significantly increased
in CON 72 and 96 hours post-operatively (P< 0.001). There was no difference for
fibrinogen (P=0.43), MNT (P=0.24) or IRT (P=0.68). This study indicates using
meloxicam significantly reduces biomarkers of inflammation and indirect
measures of pain and suggests meloxicam is effective in mitigating postoperative pain in adult lactating dairy cattle.
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Introduction
Whether for a simple headache or a highly invasive surgery, most humans
would need and demand the use of pain medications to alleviate pain and return
to a comfortable state. This has also become the expectation for our beloved
house pets: dogs, cats, bird, etc. But only recently has the need for approved
analgesia for food and fiber animals become a concern, receiving attention from
not only veterinarians and producers but by the general public as well. Many
surveys have been conducted asking consumers about their perceptions of food
and fiber animals’ well-being. In a survey to the general public about their
perspective on the ideal pig farm, respondents cited humane treatment as an
important aspect to include (Sato et al., 2017). In a survey polling Australians,
respondents from the general public had a better perception of castrations and
disbudding when some form of pain management was given (Phillips et al.,
2009). Routine husbandry practices such as castration and dehorning have been
a part of normal production for many years, but are now perceived as painful
procedures worthy of pain mitigation by the public, producers and veterinarians.
An approved, economical, pain management modality is needed now and is both
desired and demanded by all aspects of the industry in animal agriculture.
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Basic Mechanism of Pain
What is pain?
Pain is be defined as an unpleasant sensory experience, resulting from a
noxious stimuli, arising from tissue damage caused by disease, inflammation or
acute injury. Specialized sensory neurons within tissues are excited by their
respective stimuli, which activate the pain pathway and the ultimate perception of
the painful process (Millman, 2013). The International Association for the Study
of Pain defines pain as “an aversive sensory experience caused by actual or
potential injury that elicits progressive motor and vegetative reactions, results in
learned avoidance behaviors, and may modify species specific behavior,
including social behavior.”
Pain can further be categorized into distinctive types: physiologic and
pathologic. Physiologic pain is characterized by pain caused by a noxious stimuli
causing tissue damage. This type of pain serves as a warning signal and is part
of the body’s defense mechanism to prevent tissue damage. It is well localized,
rapidly transmitted, and only exists for a brief time. The second type of pain is
pathologic pain. Pathologic pain is the pain that occurs after the tissue damage
has occurred. It is can be experienced in a number of different ways including
causalgia (a dull, burning sensation), hyperalgesia (exaggeration of sensation to
a noxious stimuli), and allodynia (exaggeration of a sensation that normally does
not cause pain). Tissue damage followed by inflammation and nerve damage is
accompanied by persistent pain, or pain that exists even after the noxious stimuli
2

has been removed. Pathologic pain is further divided into acute and chronic pain
based on duration of the sensation. Acute pain is associated with withdrawal
reflexes and protection of the affected areas. Typically, this type of pain is
associated with soft tissue injury and inflammation. An example of acute pain is
the pain present after an injury that creates a behavioral modification that
prevents overexertion and incidentally, re-injury. Chronic pain is when the
expected pain persists for longer than anticipated. Cancer pain, osteoarthritic
pain and phantom limb pain are all considered chronic pain events (Lamont et
al., 2000).
What is the function of pain?
Millman et al. (2013) states that pain's functions are to “warn the animal of
actual damage to its tissues, predict when tissue damage is likely to occur, to
warn conspecifics of the presence of danger.” (Millman, 2013). The first function
is most closely associated with physiologic pain, while the later describe changes
in behavior and are more appropriate descriptions of pathologic pain. Pain leads
to physiologic and behavioral responses such as fight, flight or freezing.
What is the basic pain pathway?
Nociception is the term used to refer to the physiologic components of the
pain pathway (Anderson & Muir, 2005a). The pain pathway consists of five
distinct steps which occur within various areas of the peripheral and central

3

nervous system: Transduction, Transmission, Modulation, Projection and
Perception.
Transduction is the conversion of a noxious stimuli (thermal, mechanical,
or chemical) into an action potential by nerve fibers present at the source, called
nociceptors. Nociceptors are classified into two groups: A-fibers and C-fibers.
When A-fibers are activated, the signal transmitted is associated with a sharp
pricking sensation. This is referred to as the “first pain”. When C-fibers are
activated, the resulting sensation is a diffuse, dull, burning sensation and is
referred to as the “second” or “slow pain” (Lamont et al., 2000; Anderson & Muir,
2005b).
These action potentials originate in the nociceptors and are then
transmitted to the central nervous system (CNS) by their corresponding afferent
nerve fibers. A-delta nerves are myelinated, larger fibers that rapidly conduct
action potentials. C nerves are smaller and unmyelinated and conduct signals
much slower than A-delta (Lamont et al., 2000).
Action potentials reach the CNS via their respective fibers and are
modulated at the level of the spinal cord. Modulation of an action potential is
facilitated by descending inhibitory neurons, which occurs in the dorsal horn of
the spinal cord. These neurons amplify or depress the signal based on several
external variables including pharmaceutical effect. Once modulated, action
potentials are projected to the brain where they are perceived as pain (Anderson
& Muir, 2005b).
4

Pain management for cattle
What is currently available?
United States Department of Health and Human Services Guidance for
Industry (GFI) #123 states that for label claims of pain alleviation, the FDA
“recommends that this indication be based on the control of clinical signs of pain
associated with a disease.” This GFI further states “We encourage the use of
validated methods of pain assessment in the target species.” Although guidelines
are in place, limited validated methods for pain assessment in cattle exist,
making new drug labeling increasingly difficult (FDA, 2006).
One product has been introduced to the market with a label specifically for
pain. Transdermal flunixin meglumine (Banamine Transdermal by Merck) is the
first drug ever for cattle to have a label indication for pain and was released in
2017. The label specifies that this product is indicated for the treatment of pain
associated with foot rot, but is not indicated for use in cattle over 20 months of
age. Despite this important advance, there still is no approved products for postoperative pain in adult lactating dairy cattle. Moreover, due to the narrow
indications for its approval the use of Banamine Transdermal for other etiologies
of pain is considered extra-label use.
Because cattle are food animals, restrictive guidelines exist to prevent
violative residues of medications and their metabolites from entering the food
supply. The Animal Medicinal Drug Use Clarification Act (AMDUCA) of 1994 was
created to provide veterinarians the opportunity to determine appropriate extra5

label uses of pharmaceuticals for veterinary species, based on their clinical
judgment. One stipulation of extra-label drug use in food and fiber species is the
lack of allowable tolerance or zero tolerance of detectable residues in meat or
milk. This means when veterinarians use drugs in an extra-label manner, any
detection of that drug or its metabolites constitutes a violation (AMDUCA, 1994).

Assessment of pain in other species
Pain assessment indicators should be specific, repeatable and sensitive.
This means that an indicator should be measuring pain and no other conditions
(specific), repeatable within and between observers, and able to detect pain even
when in low amounts (sensitive). Assessing the accuracy and precision of pain
indicators, like other diagnostic tests, should be conducted by comparing them to
a gold standard. However, there is not a gold standard for comparison when
assessing pain in animals. Therefore, many experimental studies derive efficacy
of pain management though comparison to animals receiving pain medication to
those that not, or who have received varying dosages of pain medication (Ison et
al., 2016).
Pain in other species of animals has been validated and study extensively.
Human medicine has identified multiple indicators of pain. Human pain
researchers have the advantage of patients that self-report pain. For non-verbal
patients such as infants, the elderly, or patients with language barriers, other
mechanisms including facial grimace scales such as the Wong/Baker faces
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rating scale can be used. Other non-verbal cues of pain in humans include
changes in vital signs, vocalization, and muscle tension (Fink, 2000).
There is some controversy over whether animals experience pain in the
same way as humans. Animals and humans share similar anatomical pathways
as well as similar CNS responses evoked by pain. This suggests the basis for
comparative pain perception and physiology.
In mice, a validated grimace scale, has been developed that takes into
account orbital tightening, nose bulge, cheek bulge, ear position, and whisker
changes as collective indicators of pain (Langford et al., 2010). Similar scales
have also been developed in rabbits (Keating, Thomas, Flecknell, & Leach,
2012), sheep (Hager et al., 2017) and horses (Dalla Costa et al., 2014).
In pigs, consistent behavioral changes were seen following castration, tail
docking, and needle teeth clipping including trembling, tail wagging, and head
shaking, respectively. Removal or reduction of these behaviors upon treatment
also suggests validity in the assessment of painful conditions, such as the
reduction of escape behaviors seen in piglets following administration of a local
anesthetic prior to castration. Attempts to quantify the pain threshold in pigs have
been developed through the use of nociceptive threshold testing, either by
thermal or mechanical means. In this method, a noxious stimulus is applied and
the force or length of time applied is measured as an indirect assessment of the
animal’s tolerance of the stimulus. Physiologic markers such as Fos-positive
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neurons, cortisol, substance P, and prostaglandin E2 have also been evaluated
as objective measures of pain in multiple species (Ison et al., 2016).
Several issues sited in studies of pain are the unwillingness of the animal
to show pain because an observer is present or because of sampling methods.
Many of the domesticated food animals are prey species and have the inherent
need to hide pain for their survival.

Assessment of pain in cattle
What are the methods?
Ontologically cattle are a prey species that often hide pain in order to
avoid predation. An example of this is the feedlot steer with respiratory disease
that clearly elicits clinical illness when the observer is out of sight, but may
override these signs so successfully as to be unrecognized as ill when the
observer is present. Likewise, pain can be masked when fear overrides its
physiologic manifestation. Cattle fear responses to humans are also influenced
by breed and management conditions the animal has experienced. These
responses therefore can be attenuated through positive interactions with human
caregivers, typically from a young age, or conditioning through highly repetitive
exposures. For example, a hand raised dairy calf is less likely to exhibit a fear
response to a novel human than a calf that has never seen a human.
To compound the issue, signs of pain in cattle are subject to interpretation
by each observer. Subjective measures of pain and cattle wellness vary by
8

observer training, experience, age and gender (Coetzee, 2013). When signs of
pain are overt and point to a specific limb or body area the assessment becomes
more reliable, but assessment of generalized pain can be difficult (Le Bars et al.,
2001). The most common types of pain assessment in veterinary medicine are
visual assessments where observers attempt to discern behavioral changes in
attitude, posture, or disposition. These subjective assessments can be improved
with the addition of categorization and appraisal of focal points such orbital
tightening, head and neck position, and ear position. Locomotion scoring
provides a good example where the scale for severity is divided into 4 - 5
categories and focal points of interest are back arch, stride length, and head
position (Grégoire et al., 2013; Groenevelt et al., 2014).
To directly measure pain would be to directly measure the physiologic
changes of the pain pathway. For example, measuring the frequency and
amplitude of action potentials leaving the area of the noxious stimuli as well as its
influence on structures within the central nervous system. Nerve conduction
studies and electroencephalograms can provide some approximation of this data,
but their impracticality limit implementation on a wider scale. Moreover, these
methods do not capture the impact of pain on the affective state and therefore
assessment of pain in cattle can truly only be measured indirectly.
Objective measures of pain are quantifiable and are not biased by the
observer. These methodologies produce discrete observations within animals
overtime with response variables that can be compared across treatment groups.
9

Objective measures of pain include frequency monitoring of specific behaviors,
blood biomarkers, pressure algometry, infrared thermography, heart rate
monitors and remote activity monitors such as accelerometers or real-time
location systems. Each of these methods have been used extensively in
monitoring cattle wellness and stress.
Subjective measures are those assessed by proxy and vary based on
observer experience and knowledge. These are often in the form of scales, such
as the locomotion scoring system or grimace scales. Objective measures are
those that are not biased by the observer. These include measures such as
blood metabolites and heart rate. Some indicators are somewhere in the middle.
An example would be in the case of mean nociceptive threshold (MNT). This
measures the force excreted to cause a pain reaction. Although the output is an
objective measure, the ability of the observer to recognize the painful reaction
would be subjective, making the overall observation open to possible bias due to
knowledge and experience.
Numerous indirect methods have been used to measure pain in cattle
associated with lameness, metritis, castration, and dehorning. Methods have
been both subjective and objective measures of inflammatory mediators and
stress hormones, physiologic parameters, production data, and behavioral data.
Inflammatory mediators include cortisol, haptoglobin, fibrinogen, substance P,
and serum amyloid A. Physiologic parameters include rectal temperature and
heart rate variation. Production data includes feed intake, average daily gain,
10

morbidity and mortality, dry matter intake and milk yield. Finally behavioral data
includes lying time, step lengths, feed bunk aggression/displacement, and chute
exit velocity (J. F. Coetzee, 2013a).

Physiologic parameters
PGE2
Prostaglandin E2 is a positive acute phase protein and is one of the most
important mediator for inflammatory pain (Kawabata, 2011). Prostaglandins are
produced through the arachidonic acid pathway through cyclooxygenase (COX).
Cyclooxygenase 1 is found across the mammalian body in peripheral tissues and
the central nervous system. COX-1 is important for renal and gastrointestinal
homeostasis, and its expression is increased by inflammation and pain.
Cyclooxygenase 2 is also found in the central nervous system and is present in
the cell in low numbers until the proper stimulus is provided (factors released by
dying or damaged cells) (Coetzee, 2011). Cyclooxygenase 1 and 2 convert
arachidonic acid to prostaglandin G2 which is converted further to prostaglandin
H2 by a peroxidase. This prostaglandin H2 is converted to a number of different
prostaglandins including PGE2, PGI2, TXA2, PGD2, and PGF2a
(Chandrasekharan & Simmons, 2004).
Prostaglandin E2 has an effect on the central nervous system, vascular
smooth muscle, platelets and kidneys, and is generated from PGH2 by 3
separate isomerases: cytosolic PGE synthase, microsomal PGE synthase-2, and
11

microsomal PGE synthase-1. Both cPGES and mPGES-2 are widely expressed
and are important for renal homeostasis and gastrointestinal protection. The
mPGES-1 is upregulated with COX-2 in response to an inflammatory mediators
leading to the production of PGE2 that creates the inflammation (Kawabata,
2011). COX-1 is responsible for the initial release of prostaglandins and is
followed in 2-8 hours by the COX-2 mediated release. Prostaglandins cause the
neurons’ threshold to lower, allowing for an increase in nociceptive activation.
PGE2 is responsible in part for the central hyperalgesia that is seen with
increased dorsal root excitability (Coetzee, 2011).
Most research on PGE2 is focused on the reduction of this molecule in
tissue through the inhibition of the cyclooxygenase pathway. Non-steroidal antiinflammatory drugs are used to decrease the inflammatory process by stopping
the production of prostaglandins and other pro-inflammatory molecules by
inhibiting the cyclooxygenases. NSAIDS will be discussed in further detail at the
end of this review.
Novel ways of inhibiting the production of PGE2 without the side effects of
NSAIDS are being explored. These possible avenues involve blocking other
areas in the cyclooxygenase pathway such as inhibiting mPGES-2 or selectively
binding PGE2 receptors antagonist. A study in guinea pigs showed that by
selectively inhibiting mPGES-1, PGE2 production is decreased apart from the
other prostaglandins involved in this pathway (Xu et al., 2008). More specifically,
a human study concluded that PGE2 is involved in the mediation of visceral pain
12

by inhibiting the receptors specific to PGE2 and mitigating the pain felt by
subjects (Sarkar et al., 2003).
Prostaglandin E2 can be measured from serum or urine. Because the
PGE2 molecule is not stable, commercial assays are available to measure the
metabolites and form an estimation of the PGE2 level.
Cortisol and CBG
Cortisol is used as a marker of stress in both humans and animals and is
produced via activation of the hypothalamic-pituitary- axis (HPA). This axis is
regulated by the hypothalamus releasing corticotrophin-releasing factor (CRF)
and vasopressin (AVP). This activates the release of adrenocorticotrophic
hormone (ACTH) from the pituitary. ACTH acts on the adrenal glands,
specifically the zona fasciculata of the adrenal cortex, to release glucocorticoids
such as cortisol. Glucocorticoids then act as negative feedback on the secretion
of CRF and AVP from the hypothalamus as well as directly on the pituitary
corticotropes to inhibit the secretion of ACTH (Pariante & Lightman, 2008).
The HPA axis is activated in response to physical and psychological
stressors. Cortisol’s role in the body focuses primarily on regulating metabolism
of the cells and reducing inflammation (Ison et al., 2016). Excessive, sustained
amounts of cortisol in the blood is referred to as hypercortisolism, and is
commonly known as Cushing’s disease. An insufficient level of cortisol in the
body is known as hypocortisolism, and is commonly known as Addison’s or
Nelson’s disease.
13

Cortisol levels are affected by the intensity, duration and site of the noxious
stimuli, and are not a measure of pain directly, but is an evaluation of the body’s
response to distress. Activation of the HPA is prompted by a variety of physical,
emotional and physiological challenges including surgical procedures, anxiety,
unusual handling, extreme temperature changes, vigorous exercise and many
other stimuli (Mellor et al., 2000). Other stressors affecting the plasma cortisol
levels in dairy cattle include age, diet, milk yield, and environmental factors
(Dunlap et al., 1981). Cortisol may have a maximum level it can reach in the
body. In a study by Coetzee et al. 2008, simulated castration and surgical
castration had similar plasma cortisol levels, which suggest that handling alone
can reach the maximum threshold for cortisol levels. Since cortisol can rise from
the handling alone, sample collection could cause an increase and lead to
confounding results. To further complicate cortisol evaluation, endogenous
cortisol secretion has a diurnal rhythm of secretion and is variable between
individuals (Coetzee et al., 2008). After administration of exogenous cortisol, beef
cattle’s clearance rate of the cortisol was approximately 30 minutes (Dunlap et
al., 1981).
Cortisol levels are also affected by the use of local anesthetics. In a study
evaluating cortisol and dehorning, calves dehorned with the use of a local
anesthetic had a slight rise in cortisol as a result of handling and had a second,
large rise in cortisol after the local anesthetic wore off (Mellor et al., 2000).
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Corticosteroid-binding globulin (CBG) is the major binding protein in the blood
for cortisol and is produced by the liver. CBG has a high affinity for cortisol and
binds 75% of total cortisol. Free cortisol makes up 10% of total cortisol levels,
with another 15% bound to albumin. CBG can bind up to approximately 25 µg/dL
of cortisol in the plasma. Once this level of binding is reached, the free cortisol
level increases rapidly to exceed the usual 10%. This unbound portion of cortisol
is the active cortisol that is regulated through the HPA axis. In humans, CBG is
increased during pregnancy, hyperthyroidism, diabetes and some genetic
disease and is decreased in hypothyroidism and protein deficiencies seen with
severe liver disease (Carroll et al., 2011).
In the face of inflammation, CBG has been defined as a negative APP,
meaning it decreases in response to inflammation. This decreases the bound
cortisol carrying capacity in the blood and would increase the amount of free
cortisol. Because free cortisol has a short half-life, the total cortisol level may not
change or are underestimated if CBG is decreased (Trevisi et al., 2013).
Free Cortisol Index (FCI) is the total cortisol to CBG ratio. This has been used
as a correlate of serum free cortisol. In a human study following healthy adults
through major elective surgeries, FCI increased by 130% while total cortisol rose
55% and CBG fell 30%. This measure takes into account CBG’s role in cortisol
levels and its effect on cortisol measurement and interpretation (le Roux et al.,
2003).
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Haptoglobin and MMP-9
Haptoglobin (Hp) is a major positive acute phase protein (APP) in cattle
produced by the liver and is one of the most specific APPs for inflammation and
infection. In healthy adults, Hp is present at less than 0.1 g/L. In acutely ill adults,
Hp levels increase over 100-fold and reach maximum levels between 48 and 96
hours (Bannikov et al., 2011). Bovine Hp is made of an alpha and beta chain
linked by a disulfide bond (Ceciliani et al., 2012) Hp increases during the acute
phase of both infectious and inflammatory conditions such as those following
surgical trauma (Chan et al., 2004). Hp also increased in times of stress due to
increased levels of circulating cortisol (Guzelbektes et al., 2010). It has also been
used to distinguish between chronic and acute inflammation due to the
significantly higher levels in the acute phase of inflammation (Paulina & Tadeusz,
2011).
A major function of Hp is to scavenge hemoglobin released by damaged
red blood cells. Once bound, the two proteins form a stable complex that is taken
up by macrophages for breakdown (Alayash, 2011). This allows haptoglobin to
act as an anti-oxidant against the oxidative damage that hemoglobin can cause.
Hp is also responsible for some regulation of the innate immune response of
white blood cells and has bacteriostatic effects (Ceciliani et al., 2012). It is
essentially an anti-inflammatory during this process. Macrophages upregulated
anti-inflammatory mediators in response to hemoglobin-haptoglobin complexes
binding to CD163 receptors. The anti-inflammatory mediators released include
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IL10 and heme oxygenase-1 which activate the anti-inflammatory response
further. Haptoglobin also downregulate neutrophil activity directly by inhibiting
lipoxygenase and cyclooxygenase or by inhibiting the respiratory burst. Hp
further inhibits the Th2 cytokine release to suppress T cell proliferation. Finally,
bacteriostatic activity of Hp is achieved when bacteria that need iron to grow are
inhibited by Hp due to its scavenging of free hemoglobin. Bacteria can overcome
the binding to utilize the heme if they are have an iron acquisition system
(Ceciliani et al., 2012).
In cattle, haptoglobin is used for the diagnosis and prognosis of several
diseases including mastitis, enteritis, peritonitis, pneumonia, and metritis. The
reproductive tracts of cattle also have Hp expression that some have
hypothesized are part of the normal physiology of the tract. Hp also increases in
response to disease of the reproductive tract. Dairy cattle with increased
metabolic stress (measured through beta-hydroxybutyric acid) at the time of
calving were found to have increase Hp. Cows with retained fetal membranes
and those multiparous cows with assisted calving also had increases in
haptoglobin levels (Pohl et al., 2015).
Hp is expressed in high rates in the liver but is also seen in the abomasum
and forestomaches. Because the forestomach is continuously exposed to
microbes, this explains the need for Hp as a part of the immune system dealing
with possible breaches in the epithelium (Dilda et al., 2012).
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In cattle, increased expression of Hp is seen with LPS infusion into the
mammary gland as well as E. coli infections. Haptoglobin has been used as an
indicator of disease in cattle for many years. A study measuring haptoglobin in
milk verses serum found that animals administered LPS directly into the
mammary gland showed an increase in Hp both in the blood and in the milk (Hiss
et al., 2004).
In the future, Hp may be a useful tool in slaughterhouses to assist with the
meat inspection process. In a study comparing Hp levels of dairy cows with
infection and metabolic disease, Hp levels were 6-fold higher than in animals with
minor lesions. In a separate study, Hp was 40-fold higher dairy cows with acute
lesions than healthy animals (Eckersall & Bell, 2010).
Matrix Metalloproteinase 9 (MMP 9) is a zinc dependent proteinase in the
gelatinase B group. They are stored in neutrophils and released during
degranulation. They are able to breakdown the extracellular matrix and
components of the basement membrane which increases white blood cell
migration during inflammation. MMP 9 is also capable of activating IL-8 creating
a positive feedback loop for more neutrophil recruitment. The Hp-MMP 9
complex forms in the neutrophil and are stored here until degranulation. The
release of this complex represents neutrophil activation. Measuring the Hp-MMP
9 complex allows to differentiation of acute and chronic inflammation since it is
only released by activated neutrophils in response to acute inflammation
(Hanthorn et al., 2010). A study compared ELISAs for free Hp, free MMP 9 and
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Hp-MMP 9 complexes in acute infection, chronic infection and healthy cattle.
The results showed Hp-MMP 9 was not detectable in healthy animals and was
the highest in animals with acute inflammation (Bannikov et al., 2011).
Fibrinogen
Fibrinogen is a moderate positive APP in cattle and found in healthy
animals between 1.58-2.94 g/L (Ceciliani et al., 2012). The liver is the major
organ for Fb production, where liver parenchymal cells produce and store Fb until
it is needed. The major role of Fb in the body is as a precursor for fibrin formation
and a molecule in the coagulation cascade. Fb levels following tissue damage
increase within 24 hours and decreases once its maximum concentration is met.
In cases of disease causing Fb to be increased, levels remain high until the
disease has subsided (McSherry et al., 1970).
In a study by McSherry 1970, 9 cows presented with displaced abomasa
(DA). Three of these had fibrinogen levels greater than the reference range
(range: 9.0-10.25 g/L). The six remaining cows were within the reference range
(3.1-8.0 g/L) (McSherry et al., 1970). This was also seen in several other studies
looking at fibrinogen in response to naturally occurring DAs. In a study by Jawor,
seven cows that presented with a DA had fibrinogen levels within the
physiologically normal range with only one elevated. This animal also had
bronchitis as a concurrent disease (Jawor et al., 2009).
In a study of naturally occurring abdominal disorders (LDA, RDA and
dystocia), Fb levels were within the reference range (3.0-7.0 g/L) prior to surgery.
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Furthermore, surgical intervention did not elevate the levels of Fb on a systemic
level. This study also evaluated naturally occurring traumatic reticulo-peritonitis.
These animals had a significantly higher concentration of Fb than all other
groups (mean: 11.6 g/L) which increase slightly following surgery and then
lowered over time. These authors further suggest that fibrinogen is more specific
to infectious causes of disease and that an increase after surgery would be more
indicative for peritonitis associated with surgery (Hirvonen & Pyorala, 1998).

Mean Nociceptive Threshold
Mean Nociceptive Threshold (MNT) is measured by the application of a
continuously increasing stimuli applied to tissues that reaches a pain tolerance
threshold and causes a withdrawal or avoidance response. This threshold
represents the maximum pressure (or pain) the subject is willing to suffer before
a response is occurs. Several stimuli have been used including electrical,
thermal, chemical and mechanical. These stimuli are applied to the tissues and
produces a quantifiable outcome that is repeatable and is non-invasive.
Electrical stimulation meets the criteria for repeatability, quantification and
non-invasiveness. However, this type of stimulus stimulates not only nociceptive
fibers but also large diameter fibers used for hot and cold sensation. This
stimulus is not typically found in the animal’s natural environment and
effectiveness of the test may vary due to difference in impedance of different
tissues. Thermal stimulation also meets the criteria needed for an MNT method.
This type of stimulation does cause the activation of thermoreceptors as well as
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nociceptors. One of the disadvantages see with this type of stimulation is the
difference seen over black or darker areas of skin. This was demonstrated in a
study of guinea pigs where black animals had a nociceptive threshold 8% lower
than white animals when radiant heat was used. For chemical stimulation, an
algogenic agent is administered and causes a slow stimulus over a longer period
of time than the other stimuli listed. This type of stimulus is unique from others
because the measured outcome is a measure of behavioral changes in response
to an inescapable stimulus (Pongratz & Licka, 2017).
The final type of nociception stimulus, and the focus of this section, is
mechanical stimulation. An algometer is used to quantify the threshold based on
a force exerted on the tissue. This method’s use in damaged tissues is based on
the association of inflammation from tissue damage causing hyperalgesia or
allodynia. (Di Giminiani et al., 2016). This type of stimulus will also activate
mechanoreceptors in the tissues as well as nociceptors (Pongratz & Licka,
2017).
The mechanical stimuli are applied until a response is obtained. Examples
of responses to stimuli in mice and rates include tail flicking or paw withdrawals.
In cattle, the responses measured include withdrawing the head after dehorning
(Heinrich et al., 2010), moving away from the device, looking back at the device,
tail flicks, and kicking.
Several principles have been demonstrated when using an algometer as
a measure of pain. Tissues that are damaged whether from disease or surgical
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trauma will have a lower threshold than those tissues that are healthy. Smaller
algometry tips result in a lower MNT while larger tips result in a higher MNT
(Pongratz & Licka, 2017). A certain level of variability is always present and is
multifactorial.
In a study of pain in dogs undergoing ovariohysterectomy and
ovariectomy, algometry was used to measure cutaneous pain of the incision site.
During this study a response was classified as a sudden movement away from
the algometry unit, attempting to stand, looking at the algometry unit,
vocalization, and attempting to bite. This study showed no difference in the two
surgeries when comparing algometry reading, but the authors do state there is
not an effective way of testing pain from within the peritoneal cavity at this time
(Tallant et al., 2016).
In a study of horse back pain, algometry tips were compared based on the
diameter and how they elicited a response. This study found that tips with a
contact area of 1 cm2 produced more similar results than larger or smaller tips.
Furthermore, the shape of the tip was examined. Rounded (hemispheric shape)
rips resulted in a higher pain threshold than cylindrical, flat tips. This study also
compared measurements in the thoracic region verses the lumbar region of live
horses. Because there is increased tissue thickness in the lumbar region, this
area had a higher threshold than the thoracic region (Pongratz & Licka, 2017).
In a study assessing the effects of meloxicam on dairy calves after cautery
dehorning, calves were tested with a pressure algometer. Calves treated with
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meloxicam were less sensitive to algometry 4 hours after dehorning when
compared to calves without meloxicam (Control MNT = 1.62 ± 0.13 kg of force;
Meloxicam MNT = 2.13 ± 0.15 kg of force) (Heinrich et al., 2010).
This method has further been used as a way of objectively determining
claw pain relation to locomotion scoring in dairy cattle. In this study, algometry
was used to measure the pain in claws. The response to a stimulus in this study
was withdrawal of the foot (Dyer et al., 2007).
Algometry has several factors that make the results less reliable.
Individual variation is one of the biggest factors affecting results for algometry. An
individual’s sex, breed, age, body condition, and overall pain tolerance effect its
MNT. The stage of disease or stage in the healing process affect the response to
stimuli such as pressure readings. Algometry is also affected by the operator. In
most studies, algometry is carried out by one operator who has been trained on
the possible responses the subject by exhibit that require removal of the
pressure. Algometry is limited by the need for repeated measurements. While
triplicates are required for many statistical readings, subjects may become
habituated to these readings over time. One of two scenarios could occur. One,
the animal becomes habituated to the noxious stimuli, and its threshold will be
falsely increased. Two, the animal begins giving the desired avoidance response
earlier than originally intended in order to avoid the experience all together
causing a false decrease in the threshold.
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Thermography
“Running a fever” has long since been a telltale sign of sickness.
Hippocrates speculated that when a patient was covered in mud, areas that dried
faster had greater heat and were therefore diseased. Since the invention of the
thermometer in the 17th century, body temperature has been used as an
objective and quantitative means to measure sickness and its severity. An
increased body temperature can tell physicians that body is fighting off infections,
has an increase in inflammation, or is overheating due to the environment.
Infrared thermography is being used in many fields to distinguish
temperature differences, from law enforcement using this technology to rescue
people to building engineers using this to detect heating leaks from a building.
Now medical personnel are exploring the possibilities of how infrared
thermography can help diagnose and monitor medical conditions.
This modality is helpful in measuring the sympathetic adrenomedullary
system. In a fight or flight response, skin temperature decreases as blood
vessels constrict in the periphery to move more blood to the muscle and internal
organs. IRT is also helpful in measuring inflammation and pyrexia. The five
cardinal signs of inflammation are heat, redness, swelling, pain, and loss of
function. Temperature in inflammation increases due to vasodilation of the
vessels at the area to increase blood flow which is also accompanied by
inflammatory mediators such as cytokines, eicosanoids, and complement
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proteins. These mediators work to activate PGE2 that then acts on the preoptic
area in the brain to increase overall body temperature (Bradford et al., 2015).
Thermal imaging is being used as a screening tool in animals and humans
for a change in overall body temperature and the assessment of local
inflammation. This method allows for assessing temperatures noninvasively and
requires no physical contact between subjects and screeners. Thermal imaging
was used to screen people at airports for increases in body temperature during
the avian influenza outbreaks. It has been used experimentally for the detection
and monitoring for foreign animal disease such as foot-and-mouth disease virus
and bluetongue virus, monitoring wildlife for infectious diseases such as rabies,
and decreasing the time needed for testing for tuberculosis in cattle (Rekant et
al., 2016).
Many studies have demonstrated the use of IRT for screening patients for
increased body temperature [due to a febrile state]. In a study in calves
inoculated with a high virulent type 2 Bovine Viral Diarrhea Virus (BVDV),
infrared thermography of the eye was used to detect disease as early as 1 day
post experimental inoculation, which was significantly different from preinoculation temperatures, and coincided with the expected course of disease.
This correlated with changes in rectal temperature. In this study, thermal images
were taken of the side, back, hooves, ears, nose and eyes as well as samples of
serum cortisol, haptoglobin and salivary IgA levels. Ocular infrared temperatures
were the most reliable and consistent for detection of disease (A. L. Schaefer et
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al., 2004). Because of this work, any disease that causes an animal to become
febrile (bovine respiratory disease complex, metritis, peritonitis, etc.), can be
detected and monitored earlier than by other traditional method without having a
direct interaction with the patient.
Thermal imaging has also been used for the detection and monitoring of
localized inflammation in cattle such as hoof lesions or mastitis. These localized
inflammatory processes are characterized by the dilation of blood vessels,
hyperemia, swelling, and hyperthermia. (Rekant et al., 2016). In a study of dairy
cattle, IRT was compared to the California Mastitis Test (CMT) on its ability to
detect subclinical mastitis. The udder skin surface temperature (SST) and CMT
were positively correlated, while rectal temperature had a weak correlation to
both (Colak et al., 2008). In a study of lameness in dairy cattle, temperature
increases in the hoof with a lesion were observed before behavioral signs
became evident and decreased once corrective trimming was performed to
alleviate the lesion (Wood et al., 2015).
Thermography’s use in detecting inflammation has become even more
important when assessing the welfare of animals. Inflammation in the limbs of
gaited horses caused by soring is being detected by governing official using IRT
as an objective adjunct tool.
One of the greatest advantages of IRT is the ability to collect individual
data by a remote, noninvasive means. Observers are able to essentially snap a
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picture of a location of interest and have a diagnostic picture of the animal’s
health or a screening tool for monitoring herd health.
Cow factors that would affect the quality of the thermal image include hair
vs non-haired skin, color of skin, and age. Hair is an insulator, which holds heat
to the body and out of sight from the IRT camera. For this reason, haired skin
tends to appear cooler than non-haired skin. This remains true in the case of
clipping for a surgical procedure. Black also absorbs heat more than lighter
colors. In black and white colored cows, the black areas will be warmer than
white areas. Finally, age has been shown to have a possible effect on body
temperature of the eye in human subjects. Other areas where not studies but can
be inferred to also affect theses as well.
Environmental factors that can affect the quality of the thermal image
include ambient temperature, air movement, sunlight, rain, and various other
weather conditions. With the great variety of climate changes throughout a day
and the small window of precision that the IRT camera has, the likelihood that the
environment may alter outcomes is relatively high. For this reason, evaluating
animals in controlled environmental conditions is imperative for the evaluation of
thermal images. Further factors in the environment are the presence of moister
and debris on the subject. These can limit the use of IRT in veterinary medicine
and in practical implication in the field (Rekant et al., 2016).

27

Meloxicam
Non-steroidal anti-inflammatory drugs (NSAID) are one of the options
veterinarians have for treating pain and inflammation in cattle. NSAIDs inhibit
cyclo-oxygenase enzymes (COX) from acting on the arachidonic acid pathway
and producing prostaglandins as well as other inflammatory mediators, thereby
decreasing pain and inflammation. COX is found in two isoforms: COX-1 and
COX-2. COX 1 is primarily related to homeostats of the abomasal mucosa and
renal perfusion and is constantly expressed in the CNS and PNS. Long term
alteration in COX-1 expression can lead to effects of the medications such as
ulceration of the abomasum. COX-2 is found in the CNS constantly, but is
induced by release of factors from injured tissue. This leads to its role as a major
enzyme in prostaglandin production. After a tissue insult, COX-2 mRNA
expression takes 2-8 hours to reach maximum levels. For this reason, COX-1 is
predominantly responsible for the initial release of prostaglandins (Coetzee,
2013b). Medications that are more selective for COX-2 are thought to be less
potent (Anderson & Edmondson, 2013)
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) in the
oxicam class. Meloxicam is more selective for the COX-2 isoform. The dose
approved by the European Union is currently 0.5 mg/kg IM or SC and has a 15day meat withdrawal and a 5-day milk withdrawal time.
Meloxicam is currently approved in the USA for use in dogs and cats. In
dogs, meloxicam is approved for use to control pain and inflammation associated
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with osteoarthritis ("Metacam Injectable for Dogs"). In cats, meloxicam is labeled
for control of post-operative pain and inflammation from spays, neuters, and
orthopedic surgery. This label does have a box warning stating that repeated
doses in cats is associated with acute renal failure and death ("Metacam
Injectable for Cats").
There are a number of studies evaluating meloxicam’s efficacy in cattle for
several different indications. The American Association of Bovine Practitioners
guidelines for castration and dehorning sites meloxicam as a possible long-acting
pain medication to mitigate pain associated with these procedures (Practitioners,
2014). Allen and colleagues (Allen et al., 2013) found that calves treated with
meloxicam had significantly lower cortisol levels at 4 hours after dehorning and
substance P levels at 120 hours than control calves regardless of time of
meloxicam administration (either 12 hours pre-procedure or at time of
procedure). Heinrich and colleagues (Heinrich et al., 2010) found that calves
treated with meloxicam 10 minutes prior to dehorning flicked their ears less
during the first 44 hours, had less head shaking during the first 9 hours, and were
less sensitive to pressure algometry at 4 hours after the procedure than the
control calves. Barrier and colleagues (Barrier et al., 2014) found that beef cows
given meloxicam following caesarean section spent more time lying and had
more lying bouts than control animals, suggesting that increased lying times are
representative of increased comfort.
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Coetzee and colleagues (Coetzee et al., 2009) evaluated the pharmacokinetics
of meloxicam in ruminant calves receiving the medication either orally (1 mg/kg)
or intravenously (0.5 mg/kg). Oral meloxicam had a mean peak plasma
concentration of 3.10 µg/mL at 11.64 hours with a half-life of 27.54 hours.
Intravenous administration of meloxicam had a half-life of 20.35 hours. Malreddy
and colleagues evaluated the pharmacokinetics of meloxicam in lactating dairy
cattle when given orally with two different dosing levels of gabapentin. Oral
meloxicam had mean peak plasma concentration of 2.89 µg/mL at 11.33 hours.
The mean peak milk concentration was 0.41 µg/mL at 9.33 hours (Malreddy et
al., 2013).
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Chapter 1
Markers of Pain Mitigation in Cattle Following Soft Tissue
Surgery

31

Amber F. Moore, DVM1; Marc Caldwell, DVM, PhD1,*; Brian K. Whitlock, DVM,
PhD1; Lew Strickland, DVM, MS2; Peter Krawczel, MS, PhD2; Liesel Schneider,
PhD2; David E. Anderson, DVM, MS1
1

Department of Large Animal Clinical Sciences, University of Tennessee,

Knoxville, TN 37996
2

Department of Animal Science, University of Tennessee, Knoxville, TN 37996

* Corresponding author: mcaldwell@utk.edu

Abstract
Mitigation of pain for surgical procedures has become a topic of concern
for the public, producers, and veterinarians. The objective of this study was to
determine the efficacy of meloxicam for pain mitigation in adult lactating dairy
cattle following a right-side laparotomy with omentopexy. Twenty-four dairy cattle
(mean age: 2.51 +/- 0.54 years), between 50 and 188 days in milk (median: 117
days +/- 43.15 days) were enrolled. Cattle were administered a 7-day acclimation
period to the new environment and social hierarchy and assigned blocks based
on parity, days in milk, milk yield, and pregnancy status, and randomly allocated
to groups Meloxicam (MEL) or placebo treated control (CON). The study had two
phases; sham (day 0-14) and surgery (day 15-28). The objective of the sham
phase was to collect baseline behavioral and physiologic data and permit cows to
become acclimated to human intervention during the intensive sampling periods.
On day 0, cattle were prepared for surgery including local blocks with lidocaine.
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Injectable meloxicam (MEL) or saline placebo (CON) was administered (dose:
0.5 mg/kg) 5 minutes before simulated surgery (restraint for 30 minutes) and then
returned to their home pen for data collection. On day 15, after a 14-day washout
period, the surgical procedure was performed. Meloxicam and saline were
administered prior to surgery to each respective group. A right flank laparotomy,
brief abdominal exploration, and omentopexy was performed on all animals.
Blood was collected via jugular catheter at hours 0, 2, 4, 8, 12, 24, 36, 48, 60, &
72 during both phases for cortisol, and at hours 0, 2, 4, 8, 12, 24, 48, 72, 96, 120,
144, & 168 for haptoglobin, PGE2, and fibrinogen. PGE2 concentrations
displayed a treatment by time interaction where concentrations were higher in the
CON animals (P = 0.003). Total cortisol concentrations were significantly
increased in CON 4 hours post-operatively (P=0.004). Haptoglobin was
significantly increased in CON 72 and 96 hours post-operatively (P< 0.001).
There was no difference for fibrinogen (P=0.43). This study indicates the use of
meloxicam significantly reduces biomarkers of inflammation and indirect
measures of pain and suggests meloxicam is effective in mitigating postoperative pain in adult lactating dairy cattle.

Introduction
Cattle undergo painful livestock management procedures every day such
as dehorning and castration as well as surgical repairs of displaced abomasum
(DA), rumenotomies, and caesarian section (C-section). According to the United
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States Department of Agriculture (USDA), there are an estimated 9.4 million
dairy cows in the US in 2018 (Cessna, 2018). The incidence of left displaced
abomasum (LDA) in lactating dairy cattle is approximately 5% with a projected
cost of $250 to $450 per case (van Winden, 2002). Therefore, approximately
470,000 cows undergo surgical correction for LDAs each year. Veterinarians
scored abdominal surgeries, such as DA corrections and caesarian sections, as
the most painful procedures cattle undergo with an average pain score of 7.3 and
8.0, respectively (Fajt et al., 2011). To address pain mitigation, practitioners used
a variety of medications including nonsteroidal anti-inflammatory drugs
(NSAIDS), opioids, α2 adrenergic receptor agonist, local anesthetics, or a
combination of these for pain in response to surgery.
Although practitioners are aware of the pain induced with abdominal
surgery and use a wide variety of medications to alleviate pain, only one
medication is currently labeled for the mitigation of pain in cattle. The recently
approved transdermal flunixin meglumine (Banamine® Transdermal, Merck
Animal Health, 2017) has a label indication for pyrexia associated with bovine
respiratory disease and control of pain associated with foot rot. However, this
product is not currently labeled for use in dairy cattle over 20 months of age. This
obligates practitioners to continue to use medications in an Extra Label Drug Use
(ELDU) manner under the guidance of the Animal Medicinal Drug Use
Clarification Act (AMDUCA). The cattle industry needs new products labelled
specifically for post-operative pain that are safe, effective and cost efficient.
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Meloxicam, although not approved for use in cattle in the United States, is
widely used for pain and other indications in cattle of many ages and production
systems. In Canada, meloxicam (Metacam®20, Boehringer Ingelheim (Canada)
Ltd., Burlington ON) is indicated for calf diarrhea, mastitis, and the relief of pain
associated with dehorning and abdominal surgery. Meloxicam acts by inhibiting
cyclooxygenase enzymes from converting arachidonic acid to prostaglandins and
prostacyclins. There are two isoforms of the COX molecule: COX-1 and COX-2.
COX-2 is present in low levels within the cell and is upregulated in response to
inflammation. Meloxicam preferentially inhibits COX-2 thereby decreasing the
inflammatory mediators release and depressing the inflammatory response.
Following a single subcutaneous dose, meloxicam displays peak plasma
concentrations in 7.7 hours (Cmax = 2.1μg/ml) and an elimination half-life of
approximately 22 hours in young cattle (Stock & Coetzee, 2015). Meloxicam’s
efficacy in alleviating pain associated with castration and dehorning has been
well documented (Allen et al., 2013; Brown et al., 2015; Heinrich, Duffield,
Lissemore, & Millman, 2010; Melendez et al., 2017). Barrier et al. recently
demonstrated changes in lying time and lying bouts in beef cows undergoing
emergency caesarian section following a single subcutaneous dose of
meloxicam. Likewise, meloxicam treated cattle displayed a higher dry matter
intake and altered lying time after implantation of a rumen fistula compared to
ketoprofen treated cattle (Barrier et al. (2014).
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A major hurtle in the approval of new pain medications is the ability to
objectively measure and quantify pain in cattle to meet FDA specifications ("GFI
#123-Target Animal Safety-Approval of NSAIDS,"). Pain is an inherently variable
and individual response, influenced by temperament, breed, and each animal’s
physiologic and/or affective state. Current research methodology attempts to
quantify pain indirectly through inflammatory or neuropeptide biomarkers,
changes in behavior, or changes in production parameters. Cattle are
ontologically prey species, and are behaviorally conditioned to mask pain or
disease in order to avert predation. Therefore, the pursuit of systemic biomarkers
that are byproducts of the pain or inflammatory response are attractive for
evaluating the efficacy of pain therapies in clinical studies. To the authors’
knowledge, no previous studies have evaluated the efficacy of meloxicam in
alleviating post-operative pain in lactating dairy cattle.
Thus, the objective of this study was to evaluate the efficacy of
subcutaneously administered meloxicam in alleviating post-operative pain in
lactating dairy cattle following elective laparotomy with prophylactic omentopexy.
Our hypothesis was that cattle administered meloxicam would demonstrate lower
concentrations of relevant biomarkers associated with pain and inflammation
(cortisol, CBG, PGE2, Hp, Hp – MMP9 complex, and fibrinogen) compared to
placebo administered cattle.
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Material and methods
The University of Tennessee Institutional Animal Care and Use Committee
approved all experimental procedures under the supervision of the university
veterinarian (Protocol # 2246-0314).
The study was conducted in two phases. Animals were first subjected to a
sham surgical procedure to ensure habituation to the intensive sampling
procedures followed by application of the surgical procedure after a 14-day wash
out period. Data are presented in relationship to each phase.
Animals
Twenty-four adult dairy cattle, greater than 20 months of age (mean age:
2.51 +/- 0.54 years), were housed at the East Tennessee Research and
Education Center - Little River Dairy Animal and Environmental Unit (Latitude:
35.772115; Longitude: -83.850182) during the months of June, July and August
and were maintained in an ambient temperature. Animals were between 50 and
188 days in milk (median: 117 days +/- 43.15 days) and weighed between 512 kg
and 705 kg (mean: 596.4 kg +/- 41.8 kg). Cows were allocated into two equal
groups: Meloxicam (n = 12; MEL) and Control (n = 12; CON). Groups were
balanced based on days in milk (Median: 111 days MEL; 127 days CON; Range:
50 – 188 days), milk yield (Mean: 74.0 lbs. MEL; 77.5 lbs. CON; Range: 57.6 –
93.1 lbs.), and pregnancy status (n = 2 MEL; n = 2 CON). Exclusion criteria for
enrollment in the study included clinical signs associated with potentially
systemic inflammation (i.e. mastitis, metritis, ketosis, lameness, etc.) or history or
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evidence of previous abdominal surgery. All animals were considered healthy
based on a physical exam performed by a veterinarian 1 day prior to the start of
the study.
Cattle were housed in a free stall barn approximately 20 m x 12.5 m (800
sq. m) with 24 sand-bedded stalls and 32 headlock stanchions. Stocking density
was maintained at 75% and did not exceed 100% during the study (lowest was
22 cows per 24 stalls = 91%). Cattle were milked twice daily (at approximately
7:30 AM and 4:30 PM). Milk was discarded throughout the entire of the
experiment. A total mixed ration (TMR) was fed ad libitum during the study and
was formulated according to Nutrient Research Council requirements to meet or
exceed nutrient requirements of lactating dairy cattle. Nutrient analysis of TMR
was conducted prior to and upon completion of the study. Fresh TMR was
prepared and dispensed twice daily in parallel with milking. Twice daily at
approximately 12:00 PM and 6:00 PM residual TMR was pushed up the
headlocks. Waste TMR was collected twice daily immediately prior to the
dispensing of each new feeding and weighed to determine pen level feed intake.
Throughout the study animals were also provided ad libitum access to water. The
cattle were permitted 7 days prior to the initiation of the study to acclimate to the
new environment and social hierarchy. During this time, the cattle were also
acclimated to handling via halters and grooming to simulate the contact
associated with the intense sampling periods.
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Phase 1: Sham Procedure
In order to determine the effect of the intense sampling scheme and
experimental assessments alone without the influence of the surgical procedure,
a sham experimental phase was imposed on the cattle. On day -1, a 14-gauge X
13 cm polyurethane IV jugular catheter (MILACATH-Extended Use, Mila
International, Inc. Florence, KY) was placed and were maintained with
heparinized saline until 4 days after the procedure, at which point they were
removed and subsequent samples taken via direct venipuncture.
On day 0, a sham procedure was performed. Cows were prepared for
sham surgery by clipping and sterilely preparing. Cows were blocked with 2%
lidocaine (90 ml or 1800 mg, local tissue infusion, VetOne, MWI Animal Health,
Boise, ID) in a line block pattern on their right side approximately 15 cm below
the transverse process of the 3rd lumbar vertebrae and 10 cm caudal to the
costal arch. Meloxicam (0.5 mg/kg, Metacam®20, Boehringer Ingelheim Ltd.,
Burlington, Ontario, Canada) was administered SQ in the neck to the meloxicam
treatment group (MEL) and saline (0.025 mL/kg, 0.9% Sodium Chloride Injection
USP, Hospira, Inc. Lake Forest, IL) was administered SQ in the neck to the
control group (CON). Ampicillin trihydrate (10 mg/kg, Polyflex®, Boehringer
Ingelheim Ltd., St. Joseph, MO) was administered intramuscularly to all cows on
the contralateral side of the neck from the treatment.
Four veterinarians were designated as surgeons during the study (MC,
DA, BW, and LS). Six replicates of sham procedures occurred with 4 animals per
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cohort. Each cohort was equally balanced for MEL and CON cattle (2 MEL and 2
CON). Each surgeon performed six procedures with equal numbers of MEL and
CON cattle (3 MEL and 3 CON). A sham surgical simulation was performed with
the surgeon standing adjacent to the animal while it was restrained for 30
minutes. Procedure initiation for each cohort was staggered and administration of
treatment and sampling time points were relative to each animal’s sham
procedure start time.
Following the sham procedure, cattle were returned to their home pen for
sample collection lasting up to 7 days. Following completion of phase 1, the
cattle were provided a 7-day washout period. Therefore, a total of 14 days
following administration of the meloxicam or saline placebo elapsed prior to
initiation of phase 2.
Phase 2: Surgical Procedure
The methods used for the phase 2 were similar to those executed during
phase 1 with the exception of preforming right flank laparotomies with
prophylactic omentopexy for all cattle. Briefly, on day -1 before the surgical
procedure, cattle were refitted with heart rate monitors and jugular catheter was
placed. As previously, jugular catheters were maintained with heparinized saline
through the first 96 hours of the sampling period then removed and subsequent
blood samples collected via direct venipuncture. On day 0, approximately 5
minutes prior to the initiation of each animals’ surgical procedure, meloxicam (0.5
mg/kg) was administered SQ in the neck to the meloxicam treatment group
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(MEL) while a saline placebo (0.025 mL/kg) was administered SQ in the neck to
the control group (CON). Ampicillin trihydrate (10 mg/kg) was administered
intramuscularly to all cows on the contralateral side of the neck from the
meloxicam or saline treatment.
The same four veterinarians carried out the surgical procedures in 6
replicates of 4 cows. All treatments were balanced within each cohort and
balanced across each surgeon. Each laparotomy, abdominal exploratory and
prophylactic omentopexy were performed according to a standardized protocol.
The right paralumbar fossa was clipped, the skin was aseptically prepared, and a
line block with lidocaine (120mL of lidocaine) was performed as previously
described. After aseptic preparation, a 15 cm vertical incision was made starting
10-cm caudal to the caudal curvature of the last rib and 15 cm ventral to the
transverse process of the 3rd lumbar vertebrae. The incision progressed through
the skin, external abdominal oblique muscle, internal abdominal oblique muscle,
transversus abdominus muscle, and peritoneum. The surgeon then placed the
left arm into the abdomen and briefly explored the abdomen to identify and
palpate the rumen, omentum and abomasum. Similar to the techniques
described in Turner and McIlwraith’s Techniques in Large Animal Surgery (2013),
a standard omentopexy was performed by suturing the omentum, peritoneum
and transversus closed using #2 polyglactin 910 (Vicryl, Ethicon, Inc. Somerville,
NJ) in a simple continuous pattern. The external abdominal oblique muscle and
internal abdominal oblique muscle were also closed using #2 polyglactin 910 in a
41

simple continuous pattern. Finally, the skin was closed using #4 nylon (Supramid
Extra II. S. Jackson, Inc. Alexandra, VA) in a continuous interlocking pattern.
Prostaglandin E2 (PGE2)
Blood samples (5 mL) were collected into a lithium heparin tube at 0
(baseline), 2, 4, 8, 12, 24, 48, 72, 96, 120, 144, and 168 after sham/surgery.
Plasma was harvested after centrifugation and frozen until analyzed. A
commercially available kit was used to measure the PGE2 metabolites
(Prostaglandin E Metabolite (Kit # 514531), Cayman Chemical Company, Ann
Arbor, MI) following previously described methodology (Fraccaro et al., 2013).
Briefly, the stable metabolite of PGE2 was measured in a competitive assay with
a PGE metabolite conjugated with acetylcholinesterase. The concentration of
PGE metabolite tracer was determined spectrophotometerically and used to
calculate the concentration of free PGE metabolite. Absorbances were read by
an ELX808 (BioTek Instruments, Inc., Winooski, VT). Intra- and inter-assay CV (n
= 570) of pooled bovine plasma was 10.7% and 4.0%, respectively.

Cortisol and Corticosteroid Binding Globulin
Blood samples (6 mL) were collected into a lithium heparin tube at 0
(baseline), 2, 4, 8, 12, 24, 36, 48, 60, and 72 after sham or surgery. Plasma was
harvested by centrifugation and frozen until analyzed. Isolation and purification of
corticosteroid-binding globulin from bovine plasma (CBG) and development and
validation of an ELISA for its quantification followed the procedures outlined by
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Roberts et al. (2003) for porcine CBG. For the CBG assay the absorbances
were read by an ELX808 (BioTek Instruments, Inc., Winooski, VT) and data were
collected using Gen5 software version 2.03.1 (BioTek Instruments, Inc.,
Winooski, VT). Intra- and inter-assay CV of pooled bovine plasma was 5.6% and
9.7%, respectively. Total serum cortisol concentration (ng/mL) was determined
using the RIA procedure of Coat-A-Count Cortisol (Siemens Medical Solutions
Diagnostics, Los Angeles, CA) as performed previously in our lab (Doherty et al.,
2007). The free cortisol index (FCI; nmol/mg) was calculated using the ratio of
plasma total cortisol (nmol/L) to CBG (mg/L; Le Roux et al., 2003).
Fibrinogen
Blood samples (6 mL) were collected into a lithium heparin tube at 0
(baseline), 2, 4, 8, 12, 24, 48, 72, 96, 120, 144, and 168 hours after the sham
and surgery procedures. Serum was harvested by centrifugation and frozen until
analyzed. Fibrinogen was measured using the heat precipitation method. Two
microhematocrit tubes were filled with plasma. The first tube was centrifuged and
the total protein was measured using a refractometer. The second tube was
heated to 56 C° for 3 minutes, centrifuged, and the total protein was measured.
This precipitates the fibrinogen from the plasma. The second protein
measurement from the heated tube was subtracted from the first protein
measurement of the unheated tube with the difference being the fibrinogen level.
The % CV of all samples (n = 576) was 8.1%.
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Haptoglobin and MMP 9
Blood samples (5 mL) were collected into a serum clot activator tube at
baseline prior to sham/surgery and hours 2, 4, 8, 12, 24, 48, 72, 96, 120, 144,
and 168 after sham/surgery. Blood were collected into a serum clot activator
tube. Serum was harvested by centrifugation after clotting and frozen until
analysis. Hp was analyzed as previously described using a commercially
available bovine haptoglobin ELISA test kit following the manufacturer’s
instructions (Hanthorn et al., 2014).
Study conclusion
A 30-day investigational withdrawal period, mandated by the food-use
authorization, was used for edible tissues following the last treatment. In addition,
a 10-day investigational milk discard time was used following the last treatment
of meloxicam.

Statistical analysis
All statistical analyses were performed in Statistical Analyses System
(SAS Version 9.1: SAS Institute Inc., Cary NC; 1991-2001). The level of
significance was established to be P< 0.05.
Normality test of the data and residuals was performed for each indicator.
Surgery total cortisol, fibrinogen, and PGE2 concentrations were normally
distributed. Surgery CBC, free cortisol index, Hp-MMP 9 and Haptoglobin
concentrations were normally distributed following log transformation. Non44

normally distributed data was log transformed to achieve normal distribution.
Data was analyzed using the GLIMMIX procedure of SAS with Tukey adjustment.
Fixed effects included treatment group. Time was used as a repeated measure.
Animal ID was used as a random effect for all blood markers. Surgeon and time
of surgery (surgery block) was analyzed as a random effect, but did not have a
significant effect on any blood markers and was therefore removed from the
analysis.

Results
Two animals were removed during the course of the study; one due to
developing mastitis (CON) and one due to surgical complications (MEL), and
have not been included in the statistical analyses. Cows included in the results is
n = 22 (n = 11 MEL; n = 11 CON).
Surgeries were performed in the unused free stall pen adjacent to the
home pen. The surgery time began when the incision was started and ended
when the last suture was tied. Surgeries ranged from 12 to 36 minutes (mean
time was 24.41 minutes). If surgeons finished before 30 minutes, cattle were
maintained in their surgical position until 30 minutes was completed. Time point 0
hours represents the start of the incision for each animal.
PGE2
During the sham procedure, there was not a treatment by time interaction
(P = 0.31). There was an effect of treatment (P = 0.02; Figure 1) and time (P <
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0.001; Figure 2) on plasma concentrations of PGE2 such that CON PGE
concentrations were greater than MEL.
During the surgery period, there was not an effect of treatment (P = 0.11).
However, there was an effect on time (P < 0.001) and a treatment by time
interaction (P = 0.003; Figure 3) on plasma PGE2 concentrations, such that the
CON group had greater concentrations at 2 and 8 hours after surgery (P= 0.004
and P<0.001, respectively).
Cortisol and Cortisol Binding Globulin
During the sham phase, total cortisol concentration was affected by time
(P = 0.016), but not significantly affected by treatment (P = 0.14), nor was there a
time by treatment interaction (P = 0.27). However, all cows displayed a decline in
total cortisol concentration over the observation period (P = 0.015, Figure 4).
CBG displayed a similar pattern were there was a time effect (P < 0.001), but
was not affected by treatment (P = 0.08) or a treatment by time interaction (P =
0.58). However, a decline in CBG over time was observed for all cows (P >
0.001, Figure 5). Finally, due to the comparative declines in both total cortisol
and CBG, the FCI had no significant time (P = 0.10), treatment (P = 0.25), or time
by treatment interaction (P = 0.17, data not shown).
Total cortisol concentration was affected by both a time across treatment
groups (P < 0.001) and a time by treatment interaction (P = 0.004) following the
surgical procedure. Figure 6 displays the least squares mean concentrations of
cortisol by treatment group over time after surgery. Cows that received
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meloxicam had significantly lower cortisol concentrations at 4 hours after surgery
(P < 0.001) than placebo-treated controls.
Unlike the observations made in the sham phase, CBG concentrations
demonstrated a significant rise over time in both treatment groups (P < 0.001,
Figure 7), but these differences were not significant by treatment (P= 0.14) or
time by treatment interaction (P = 0.52, Figure 8). Due to the overall rise in total
cortisol in the early post-operative period and the slowly rising CBG
concentration in both treatments, FCI demonstrated a significant elevation postoperatively that declined as cortisol normalized, and CBG continued a parallel
rise for both treatment groups (P < 0.001, Figure 9). However, despite the
differences in early total cortisol concentrations, there was no significant
treatment effect (P = 0.34) or time by treatment interaction (P = 0.29, Figure 10).
Fibrinogen
Interestingly, fibrinogen concentrations slowly declined over the
observation period during the sham phase (P < 0.001), despite the lack of
induced inflammation in either group, and as expected there were no treatment
(P = 0.52) or time by treatment interactions (P = 0.96, Figure 11).
During the surgery phase, fibrinogen concentration displayed a rise and
plateau between 4-hr and 144-hr post-operatively with a significant time effect (P
< 0.001, Figure 12), however there was no treatment effect (P = 0.56, Figure 13)
or time by treatment interaction (P = 0.43).
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Haptoglobin and MMP 9
During the sham procedure, Hp concentrations exhibited a peak at 72-hr
with an overall time effect for all cattle (P = 0.002), but no treatment (P = 0.42) or
time by treatment interaction (P = 0.39, Figure 14). Hp-MMP 9 complex
concentration likewise, exhibited brief spikes in concentration at 24-hr and 144 –
168-hr during the sham procedure with an overall time effect (P < 0.001), but no
treatment (P = 0.15) or treatment by time interaction (P = 0.36, Figure 15).
During the surgery procedure, Hp concentration were observed to have
both time effects (P < 0.001) and time by treatment interaction (P < 0.001), but
not a treatment effect (P = 0.66, Figure 16). Placebo-treated control animals had
significantly higher Hp concentrations are 72 and 96 hours after surgery (P =
0.015 and <0.001, respectively).
Hp-MMP 9 complex concentration, displayed a similar pattern with a peak
in concentration around 48-hr for both treatment groups (Figure 17) with a
significant time effect and time by treatment interaction (P < 0.001 and P = 0.012,
respectively), but no difference between treatments (P = 0.5317). Control cows
had a significantly lower Hp-MMP 9 complex concentration at 72 hours postsurgery. Hp-MMP 9 complex concentrations in all cows over time displayed a
significant time effect (P < 0.001, Figure 18). Complex concentrations at hours 8,
12, 24, and 48 were significantly higher in all cows following surgery.
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Discussion
This study supports the hypothesis that meloxicam is effective in reducing
pain and inflammation following soft tissue surgery. The increase in PGE2,
cortisol and haptoglobin in the control animals indicate a response to the acute
inflammation and pain following an elective laparotomy with prophylactic
omentopexy. Meloxicam reduced these markers at varying time points after
surgery in treated animals.
Surgical Model
The surgical model chosen for this study was a standing right flank
laparotomy with prophylactic omentopexy (simulated correction of an LDA). This
model accurately reproduces the sharp, acute pain associated with a surgical
procedure as well as the inflammatory pain experienced during the healing
process. All the animals enrolled in the present study recovered without
complication with the exception of one. This animal developed an intestinal
entrapment associated with the omentopexy and was subsequently exclude from
the statistical analysis on the basis of the exaggerated inflammatory response
she was perceived to be experiencing. An additional animal developed a new
intramammary infection during the study and was excluded as well on the basis
of the confounding inflammatory process. Cattle enrolled in the present study can
be characterized as early to mid-lactation (DIM: 50 – 188 days, median: 121
days). Naturally occurring displaced abomasa often occur at higher incidence
earlier in lactation, classically within the first 14 DIM and frequently occur as the
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result of or along with concurrent co-morbidities such as ketosis, hypocalcemia,
retained fetal membranes, metritis or mastitis. Likewise, cattle with disease
processes indicating surgical intervention, such as dystocia requiring Cesarean
delivery, may be in an altered physiologic state compared to the cattle
represented in the present study. Whether these co-morbidities would have
confounded the results demonstrated here is not known, but it probable that
NSAID therapy, such as meloxicam, would provide therapeutic benefit for cattle
experiencing these types of systemic inflammatory responses. Regardless, these
factors should be considered when comparing the results observed here to
clinical applications.
PGE2
The reduction of prostaglandins by NSAIDs is the main method of
analgesia and anti-inflammatory effects produced by these drugs. PGE2 is one
product of the Arachidonic Acid pathway and is upregulated by the COX-2
enzyme increases during inflammation. For this reason, PGE2 is expected to
decrease when the patient is given a COX-2 inhibitor such as meloxicam. This
has been demonstrated in several studies prior to the current one. Meloxicam
significantly reduced PGE2 concentrations in blood and synovial fluid of dogs
treated with meloxicam for 21 days. This is consistent with the suppression of the
COX-2 enzyme (Jones, Streppa, Harmon, & Budsberg, 2002).. In a human study
using whole blood and microsomal assays, meloxicam preferentially inhibited
human COX-2 at 0.01 to 1 µmol/L but was as potent of an inhibitor of both COX50

1 and COX-2 at higher concentrations. In the microsomal assay, meloxicam was
again highly selective for COX-2 (Churchill et al., 1996). Finally, in a study of
cautery dehorning in calves, meloxicam treated calves had a significantly lower
PGE2 level than control calves (Allen et al., 2013). The present study follows
these same principles of PGE2 reduction in response to meloxicam. The
reduction of PGE2 was significant at 2- and 8-hours following surgery. Some
studies even suggest that spinal PGE2 may be responsible for the increased
excitability in the dorsal root leading to hyperalgesia (J.F. Coetzee, 2011).
Because PGE2 is a known inflammatory mediator and cause pain, regulating the
magnitude of this response mitigates pain.
Inhibition of prostaglandin and prostacylin production is the primary target
of NSAID therapy. Reduction in these products, reduces the downstream
mediation of inflammation and pain. PGE2 is one product of the arachidonic acid
pathway and is increased upon induction of the cyclooxygenase-2 (COX-2)
enzyme during inflammation. For this reason, PGE2 is expected to decrease
when the patient is given a COX-2 inhibitor such as meloxicam. In fact, multiple
COX-1 and COX-2 inhibitors such as, acetylsalicylic acid, flunixin meglumine and
a celecoxib have been shown to reduce PGE2 production in in vitro isolated
bovine peripheral mononuclear cells (Myers et al., 2010). Because PGE2 is a
well described marker of inflammatory pain, regulating the magnitude of this
response mitigates pain. Moreover, it has been suggested in cattle that spinal
PGE2 may play a role in increased excitability in the dorsal root of the spinal
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cord, leading to hyperalgesia, therefore systemic administration of meloxicam
and reduction of incipient PGE2 production may decrease the overall
transduction and perception of pain (Coetzee, 2011).
In the present study, meloxicam suppressed the synthesis of PGE2 at 2and 8-hours following surgery. Although the plasma kinetics of meloxicam were
not directly measured in these animals, the reduction in PGE2 concentrations
parallel previously reported pharmacokinetics data following subcutaneous
administration of meloxicam. Other studies have demonstrated meloxicam Cmax
was reached between 6 – 8 hours following administration. Allen et al (2013)
observed a decline in PGE2 concentrations in dairy calves treated with oral
meloxicam at the time of cautery dehorning that extended out 48 hr. after the
procedure. Likewise, cattle subjected to a tissue cage implantation model,
demonstrated a 48 hr. reduction in PGE2 in the cage exudate when treated with
meloxicam following a sterile inflammatory stimulus. Other studies evaluating
meloxicam however, have not observed a concomitant decrease in PGE2
following the induction of similar painful or inflammatory conditions, perhaps
indicating the timing of meloxicam administration or the severity of the stimulus is
relevant to induction of COX-2 enzyme (Fraccaro, 2013).
Cortisol
Cortisol has been studied as a marker of the stress response associated
with pain with several models including dehorning and castration. It is an indirect
measure of the HPA axis and autonomic nervous system activation. Two studies
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evaluating the impact of meloxicam on cortisol concentration following cautery
dehorning demonstrated a peak in cortisol within 4 – 6 hours after the procedure.
This time frame suggests the pain response and activation of the HPA axis is
delayed until the effect of local analgesics had dissipated. Both groups in each
study had the benefit of local anesthesia yet, in spite of the immediate effect on
cortisol concentration in both groups, calves treated with meloxicam continued to
demonstrate significantly lower cortisol responses compared to non-treated
calves. (Allen et al., 2013; Heinrich et al., 2009). In the present study, peak
cortisol concentration for placebo-treated control cows at 4 hours postoperatively displayed a similar pattern, indicating a similar delay in induction of
the stress response after return of sensation to the previously anesthetized area.
Meloxicam treatment, however, abrogated the rise in cortisol during that time
frame and treated cattle maintained significantly lower cortisol concentration.
This suggests that, in addition to the pain mitigation of local anesthesia,
meloxicam alleviated pain sufficiently to blunt the stress response in treated
cattle.
CBG is the major binding protein of cortisol in the blood. In the face of
inflammation, CBG concentrations decrease in response to an increase of
elastase from activated neutrophils (Lewis & Elder, 2014). The degradation of
CBG releases bound cortisol, making it available at the site of inflammation, and
increasing free cortisol concentrations (Bladon et al., 1996). However, because
free cortisol has a short half-life of approximately 2 minutes and is rapidly
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metabolized, total cortisol concentrations may be unchanged or underestimated
when CBG is low (Trevisi et al., 2013). For this reason, a higher than normal total
cortisol can be assumed to be correct, whereas a lower cortisol may not be an
accurate assessment of inflammation and ongoing stress.
In this study, CBG was not significantly different between groups but did
increase over time after surgery. As a negative acute phase protein, CBG would
have been expected to decrease throughout the observation period. A rising
CBG concentration is contrary to the currently established interactions of CBG
and the inflammatory process. In humans evaluated post-operatively or during
sepsis, CBG characteristically decreases in response to inflammation (le Roux et
al., 2003: Bladon et al., 1996; Ingenbleek & Young, 1994). In these reports, CBG
measurement was made immediately post-operatively and may not accurately
reflect ongoing changes in those patients. Relevant examples of the change in
CBG in response to inflammation over time in cattle are limited, but Sharma et al.
observed a static to slightly increasing CBG concentration during the clinical
phase of anaplasmosis in cattle. (Sharma, 1986) When considered with results
from the present study, it suggests that CBG may have different induction stimuli
and more research into CBG alternations during inflammation and surgery are
warranted.
The free cortisol index is the ratio of total cortisol to CBG. This ratio
permits the assessment of cortisol that is biologically active in the context of
variations in CBG and reflects free cortisol more accurately than total cortisol
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concentrations (Dhillo et al., 2002). In the present study, FCI was did not
significantly differ between groups. However, there was a trend toward increased
FCI in non-treated cattle at 4 hours post-operative, paralleling a rise in total
cortisol at the same time point. In the face of concurrent static CBG
concentrations, this suggests a rise in free cortisol and stronger induction of the
HPA axis in non-treated cattle compared to meloxicam treated cattle.
Fibrinogen was not significantly different between treatment groups,
however there was a significant interaction between concentration and time.
Despite an elevation for both treatment groups between 4 – 120 hours, all cattle
remained within or below established reference ranges (300-800 mg/dL). This
finding is consistent with other studies where Fb was not elevated in cattle
affected with displaced abomasa and surgical correction. McSherry et al in a
review of Fb concentrations in cattle following DA correction, animals that
developed post-operative complications such as peritonitis where the only
individuals with concentrations above reference ranges, while the majority of
cattle remained normal. (McSherry et al., 1970) This suggests that the
inflammation associated with laparotomy alone is insufficient to induce a
profound Fb response. Additionally, a retrospective analysis of cattle presenting
with naturally occurring dystocia or right- or left- sided DA, surgical intervention
did not influence Fb concentration. (Hirvonen & Pyorala, 1998). In the present
study, with the exception of one animal whose data were discarded for analysis,

55

there was minimal sequalae associated with surgery and perhaps limited
induction of Fb.
Haptoglobin is a positive APP produced in the liver. In healthy adults, Hp
is present at less than 100 µg/mL. However, in acute inflammation, Hp
concentration can greater than 100-fold within 48 to 96 hours (Bannikov et al.,
2011). The limitations of Hp as a diagnostic indicator include a lack of specificity
as to the source of inflammation and extended half-life with limited discrimination
between acute and chronic inflammation (Bannikov et al., 2011). A study by
Mainau et al. (2014) found that the administration of meloxicam to naturally
calving dairy cattle, not experiencing dystocia, had no effect on Hp concentration
(Mainau et al., 2014). The lack of effect was, in their estimation, due to an
imprecise timing of administration in relation to the delivery process and an
overall lack of inflammatory response in normal births. In addition, they
concluded that cattle experiencing dystocia may still benefit from meloxicam
treatment, despite a lack of response in normal births. In the present study, Hp
concentrations were significantly increased at 72 and 96 hours after surgery in
placebo-treated control cows compared to meloxicam treated cows. All animals
were evaluated daily by blinded, experienced personnel and consistently
displayed low clinical illness scores, suggesting elevations in Hp were solely
induced by the experimental laparotomy and was significantly reduced by the
administration of meloxicam.
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The Hp-MMP 9 complex is found specifically in activated neutrophils and
is release during acute inflammation. Bannikov et al. (2011), evaluated the
diagnostic specificity of Hp, MMP-9 and the Hp-MMP 9 complex in correlation
with the severity of naturally occurring diseases. Hp concentration was increased
in cows with both acute and chronic inflammatory conditions, while un-complexed
MMP-9 concentration varied greatly and was not strongly correlated severity of
inflammation or Hp concentration. The combined Hp-MMP 9 complex however,
was elevated in acute inflammatory conditions but not in more chronic cases and
therefore, was a more accurate predictor of timing of the response than each
analyte independently. In the current study, the Hp-MMP 9 complex
concentration was significantly lower at 72 hours for control cows, in contrast to
the predicted outcome, although all cattle demonstrated a significant time effect
at 8, 12, 24 and 48 hours. These observations indicate that the experimental
surgical procedure did induce complex formation, but was not affected by
meloxicam administration.

Conclusion
Although NSAIDs, specifically meloxicam, are known to have analgesic
effects in dairy cattle, there are limited options for alleviating pain in livestock
specifically, for post-operative pain or in lactating dairy cattle. Our results
demonstrate that administration of meloxicam at a dose of 0.5 mg/kg SQ
abrogated relevant markers of pain and inflammation, namely cortisol,
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haptoglobin, and PGE2, in lactating dairy cattle following soft tissue surgery
compared to placebo-treated control animals.
The attributes of the elective surgical model described here include
uniformity in the induction of the pain and inflammatory stimulus and a more
controlled temporal comparison of treatments. Collectively, these suggest that
laparotomy with prophylactic omentopexy a promising model for the study of
post-operative pain in cattle. Pain and inflammation are common responses to
surgical procedures in cattle, and this model provides an avenue to investigate
other therapeutic techniques in the future.
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Chapter 2
Non-Invasive Assessment of Pain Mitigation in Cattle Following
Soft Tissue Surgery
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Abstract
Mitigation of pain for surgical procedures has become a topic of concern
for the public, producers, and veterinarians. The objective of this study was to
determine the efficacy of meloxicam for pain mitigation in adult lactating dairy
cattle following a right-side laparotomy with omentopexy. Twenty-four dairy cattle
(mean age: 2.51 +/- 0.54 years), between 50 and 188 days in milk (median: 117
days +/- 43.15 days) were enrolled. Cattle were administered a 7-day acclimation
period to the new environment and social hierarchy and assigned blocks based
on parity, days in milk, milk yield, and pregnancy status, and randomly allocated
to groups Meloxicam (MEL) or placebo treated control (CON). The study had two
phases; sham (day 0-14) and surgery (day 15-28). The objective of the sham
phase was to collect baseline behavioral and physiologic data and permit cows to
become acclimated to human intervention during the intensive sampling periods.
On day 0, cattle were prepared for surgery including local blocks with lidocaine.
Injectable meloxicam (MEL) or saline placebo (CON) was administered (dose:
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0.5 mg/kg) 5 minutes before simulated surgery (restraint for 30 minutes) and then
returned to their home pen for data collection. On day 15, after a 14-day washout
period, the surgical procedure was performed. Meloxicam and saline were
administered prior to surgery to each respective group. A right flank laparotomy,
brief abdominal exploration, and omentopexy was performed on all animals.
Mean nociceptive threshold (MNT) was measured using an algometer and
collected at hours 0, 1, 4, & 8 after sham and hours 0, 1, 2, 4, 8, 12, 24, 36, 48,
60, & 72 after surgery. Infrared thermography (IRT) was taken of the incision site
at hours 0, 1, 4, & 8 hours after sham and 0, 2, 4, 8, 12, 24, 36, 48, 60, & 72 after
surgery. There was no difference for MNT (P=0.24) or IRT (P=0.68). This study
indicates that meloxicam does not significantly affect these measures and that
the use of these technologies need to be studied further for its usefulness in
accessing pain in cattle.

Introduction
Cattle are frequently subjected to painful procedures related to health
interventions or production management. These may include dehorning,
castration, or surgical correction of displaced abomasum and caesarean
sections. Current practitioner and producer surveys indicate changing
perspectives on the inherent benefit of pain mitigation for livestock species. This
underscores the need for evidenced based recommendations and FDA approved
medications. At present, there are no treatments approved for the alleviation of
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pain due to soft tissue surgery in the US. Recently a transdermal flunixin
meglumine product was approved for use in treating pain associated with foot rot
in beef cattle and dairy calves, but is not approved for adult dairy cattle greater
than 20 months of age.
A major roadblock in evaluating the efficacy of pain management under
experimental conditions is the prey nature of cattle. Cattle demonstrate a
profound behavioral modification involving the masking signs of pain and distress
in order to appear fit in the presence of danger. Therefore, accurate assessment
of pain can be difficult and requires specialized equipment and training to detect
subtle behavioral cues. The cattle industry needs innovative, noninvasive
methods of detecting pain and distress in cattle. Two possible methods are mean
nociceptive thresholds and infrared thermography.
Mechanical Nociceptive Threshold (MNT) is the mean threshold at which
an animal will respond to a painful stimulus. Another interpretation is the
maximum pain stimulus an animal will endure before altering its behavior. MNT is
measured by pressure algometry were and observer consistently applies
increasing force applied to specific tissues. When a pain tolerance threshold is
breached, the stimulus induces a withdrawal or avoidance response. This
threshold can be highly modulated based on factors within the tissue such as
trauma as well as external factors such as physiologic and psychologic states as
well as the use of desensitizing medications. Following a surgical disruption of
tissue, inflammation is induced at the surgical site and is a necessary precursor
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to healing. An exaggerated or uncontrolled inflammatory process can potentially
create more sensitivity and pain. Therefore, MNT can provide an objective
assessment of the nociceptive threshold and provide a useful means of
determining the efficacy of pain therapy.
MNT has been used primarily in the detection of lameness and monitoring
sensitivity of hoof lesions in cattle. Laven et al described differences in MNT
comparing corrective trimming and/or NSIAD therapy on allodynia inducing hoof
lesions in dairy cattle (Laven et al., 2008). Raundal et al (2014) later compared
the accuracy and precision of hand held algometers in loose-housed dairy cows
and concluded that these devices poor reproducibility between observers,
suggesting that future studies habituate cows prior to application (Raundal et al.,
2014) . In a follow up study, pre-habituation prior to MNT testing, such stroking in
an attempt to remove fear of the applicator and anticipation, increased the
reliability of the test in dairy cattle (Raundal et al., 2015). These studies indicate
that while MNT can be useful to assess the pain threshold in cattle, attention to
the experimental procedure and technique is necessary to produce valid
measurements.
Infrared thermography is an imaging technique that detects radiation in the
long-infrared spectrum and translates that data into a color map or thermogram.
The amount of radiation emitted by a surface is affected by its intrinsic
temperature. In warm-blooded animals, physiologic changes, such as
inflammation or infection, that alter vascular resistance and increase blood flow
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to a tissue, subsequently increase the surface temperature of the overlying
cutaneous tissues. These changes can be monitored and provide a non-invasive
tool for clinical assessment. In cattle, thermography has been used in the
detection of hoof lesions (Stokes et al., 2012), to estimate tick infestation on
cattle (Barbedo et al., 2017), in the detection of diseases(Schaefer et al., 2012)
(Polat et al., 2010), to estimate live bull weight (Stajnko, Brus, & Hočevar, 2008),
to determine body condition score in dairy cattle (Halachmi, Klopčič, Polak,
Roberts, & Bewley, 2013), to measure stress in dairy cattle (Stewart et al., 2007),
and in monitoring health and welfare of dairy cattle (Stewart, Wilson, Schaefer,
Huddart, & Sutherland, 2017).
The objectives of the present study were to: 1) evaluate the efficacy of
MNT and IRT in assessing pain and inflammation following elective right flank
laparotomy with prophylactic omentopexy in adult lactating dairy cattle and; 2)
use MNT and IRT to determine the efficacy of meloxicam in reducing pain and
inflammation following soft tissue surgery in adult lactating dairy cattle. Our
hypothesis was that an experimental laparotomy will induce sufficient
inflammation to reduce the MNT and increase the skin surface temperature
adjacent to the laparotomy incision. A secondary hypothesis was that the
administration of meloxicam will significantly reduce the pain and inflammation
induced by the procedure such that MNT and IRT will discriminate between
treated and non-treated control animals.
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Material and methods

The University of Tennessee Institutional Animal Care and Use Committee
approved all experimental procedures under the supervision of the university
veterinarian (Protocol # 2246-0314).
The study was conducted in two phases. Animals were first subjected to a
sham surgical procedure to ensure habituation to the intensive sampling
procedures followed by application of the surgical procedure after a 14-day wash
out period. Data are presented in relationship to each phase.

Animals
Twenty-four adult dairy cattle, greater than 20 months of age (mean age:
2.51 +/- 0.54 years), were housed at the East Tennessee Research and
Education Center - Little River Dairy Animal and Environmental Unit (Latitude:
35.772115; Longitude: -83.850182) during the months of June, July and August
and were maintained in an ambient temperature. Animals were between 50 and
188 days in milk (median: 117 days +/- 43.15 days) and weighed between 512 kg
and 705 kg (mean: 596.4 kg +/- 41.8 kg). Cows were allocated into two equal
groups: Meloxicam (n = 12; MEL) and Control (n = 12; CON). Groups were
balanced based on days in milk (Median: 111 days MEL; 127 days CON; Range:
50 – 188 days), milk yield (Mean: 74.0 lbs. MEL; 77.5 lbs. CON; Range: 57.6 –
93.1 lbs.), and pregnancy status (n = 2 MEL; n = 2 CON). Exclusion criteria for
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enrollment in the study included clinical signs associated with potentially
systemic inflammation (i.e. mastitis, metritis, ketosis, lameness, etc.) or history or
evidence of previous abdominal surgery. All animals were considered healthy
based on a physical exam performed by a veterinarian 1 day prior to the start of
the study.
Cattle were housed in a free stall barn approximately 20 m x 12.5 m (800
sq. m) with 24 sand-bedded stalls and 32 headlock stanchions. Stocking density
was maintained at 75% and did not exceed 100% during the study (lowest was
22 cows per 24 stalls = 91%). Cattle were milked twice daily (at approximately
7:30 AM and 4:30 PM). Milk was discarded throughout the entire of the
experiment. A total mixed ration (TMR) was fed ad libitum during the study and
was formulated according to Nutrient Research Council requirements to meet or
exceed nutrient requirements of lactating dairy cattle. Nutrient analysis of TMR
was conducted prior to and upon completion of the study. Fresh TMR was
prepared and dispensed twice daily in parallel with milking. Twice daily at
approximately 12:00 PM and 6:00 PM residual TMR was pushed up the
headlocks. Waste TMR was collected twice daily immediately prior to the
dispensing of each new feeding and weighed to determine pen level feed intake.
Throughout the study animals were also provided ad libitum access to water. The
cattle were permitted 7 days prior to the initiation of the study to acclimate to the
new environment and social hierarchy. During this time, the cattle were also
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acclimated to handling via halters and grooming to simulate the contact
associated with the intense sampling periods.
Phase 1: Sham Procedure
In order to determine the effect of the intense sampling scheme and
experimental assessments alone without the influence of the surgical procedure,
a sham experimental phase was imposed on the cattle. On day -1, a 14-gauge X
13 cm polyurethane IV jugular catheter (MILACATH-Extended Use, Mila
International, Inc. Florence, KY) was placed and were maintained with
heparinized saline until 4 days after the procedure, at which point they were
removed and subsequent samples taken via direct venipuncture.
On day 0, a sham procedure was performed. Cows were prepared for
sham surgery by clipping and sterilely preparing. Cows were blocked with 2%
lidocaine (90 ml or 1800 mg, local tissue infusion, VetOne, MWI Animal Health,
Boise, ID) in a line block pattern on their right side approximately 15 cm below
the transverse process of the 3rd lumbar vertebrae and 10 cm caudal to the
costal arch. Meloxicam (0.5 mg/kg, Metacam®20, Boehringer Ingelheim Ltd.,
Burlington, Ontario, Canada) was administered SQ in the neck to the meloxicam
treatment group (MEL) and saline (0.025 mL/kg, 0.9% Sodium Chloride Injection
USP, Hospira, Inc. Lake Forest, IL) was administered SQ in the neck to the
control group (CON). Ampicillin trihydrate (10 mg/kg, Polyflex®, Boehringer
Ingelheim Ltd., St. Joseph, MO) was administered intramuscularly to all cows on
the contralateral side of the neck from the treatment.
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Four veterinarians were designated as surgeons during the study (MC,
DA, BW, and LS). Six replicates of sham procedures occurred with 4 animals per
cohort. Each cohort was equally balanced for MEL and CON cattle (2 MEL and 2
CON). Each surgeon performed six procedures with equal numbers of MEL and
CON cattle (3 MEL and 3 CON). A sham surgical simulation was performed with
the surgeon standing adjacent to the animal while it was restrained for 30
minutes. Procedure initiation for each cohort was staggered and administration of
treatment and sampling time points were relative to each animal’s sham
procedure start time.
Following the sham procedure, cattle were returned to their home pen for
sample collection lasting up to 7 days. Following completion of phase 1, the
cattle were provided a 7-day washout period. Therefore, a total of 14 days
following administration of the meloxicam or saline placebo elapsed prior to
initiation of phase 2.
Phase 2: Surgical Procedure
The methods used for the phase 2 were similar to those executed during
phase 1 with the exception of preforming right flank laparotomies with
prophylactic omentopexy for all cattle. Briefly, on day -1 before the surgical
procedure, cattle were refitted with heart rate monitors and jugular catheter was
placed. As previously, jugular catheters were maintained with heparinized saline
through the first 96 hours of the sampling period then removed and subsequent
blood samples collected via direct venipuncture. On day 0, approximately 5
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minutes prior to the initiation of each animals’ surgical procedure, meloxicam (0.5
mg/kg) was administered SQ in the neck to the meloxicam treatment group
(MEL) while a saline placebo (0.025 mL/kg) was administered SQ in the neck to
the control group (CON). Ampicillin trihydrate (10 mg/kg) was administered
intramuscularly to all cows on the contralateral side of the neck from the
meloxicam or saline treatment.
The same four veterinarians carried out the surgical procedures in 6
replicates of 4 cows. All treatments were balanced within each cohort and
balanced across each surgeon. Each laparotomy, abdominal exploratory and
prophylactic omentopexy were performed according to a standardized protocol.
The right paralumbar fossa was clipped, the skin was aseptically prepared, and a
line block with lidocaine (120mL of lidocaine) was performed as previously
described. After aseptic preparation, a 15 cm vertical incision was made starting
10-cm caudal to the caudal curvature of the last rib and 15 cm ventral to the
transverse process of the 3rd lumbar vertebrae. The incision progressed through
the skin, external abdominal oblique muscle, internal abdominal oblique muscle,
transversus abdominus muscle, and peritoneum. The surgeon then placed the
left arm into the abdomen and briefly explored the abdomen to identify and
palpate the rumen, omentum and abomasum. Similar to the techniques
described in Turner and McIlwraith’s Techniques in Large Animal Surgery (2013),
a standard omentopexy was performed by suturing the omentum, peritoneum
and transversus closed using #2 polyglactin 910 (Vicryl, Ethicon, Inc. Somerville,
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NJ) in a simple continuous pattern. The external abdominal oblique muscle and
internal abdominal oblique muscle were also closed using #2 polyglactin 910 in a
simple continuous pattern. Finally, the skin was closed using #4 nylon (Supramid
Extra II. S. Jackson, Inc. Alexandra, VA) in a continuous interlocking pattern.
MNT
Mechanical nociceptive threshold was measured using a pressure
algometer (Wagner Mark-10 M3, Wagner Instruments, Greenwich, CT) using a
conical steel tip (FD/S-3, Wagner Instruments, Greenwich, CT, Figure 19).
During the sham phase, MNT was measured at hours 0, 1, 4, and 8 respective to
time 0 hours beginning immediately prior to the sham procedure and during the
surgical phase at hours 0, 1, 2, 4, 8, 12, 24, 36, 48, 60, and 72 hours respective
to time 0 hr. prior to the surgical procedure. For each time point and for both
phases, the right flank adjacent to the mock or actual incision was divided into 6
test locations (Figure 20). Cows were randomly assigned to one of two starting
positions where measurements were initiated. These were either the cranial
group, where the sequence of measurements proceeded as 1, 2, 3, 4, 5, 6 or the
caudal group where the sequence proceeded 4, 5, 6, 1, 2, 3. The assignment
and sequence remained constant for each cow and all MNT measurements and
were balanced across treatment groups. Immediately prior to measurement, the
cattle were restrained using a halter or headlocks within the pen. The observer
placed a hand gently on the incision to habituate the cow to their presence before
the measurement was taken. The algometer was applied at a steady force of
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approximately 1 kgf/s to each of location until the cow presented an avoidance
response. These responses included movement away from the pressure, tail
flicking, ear twitching, looking back and kicking. All MNT measurements were
carried out by the same individual who was blinded to treatment.
IRT
Thermograms were obtained of each cow at hours 0, 1, 4, and 8 hours
beginning immediately prior to the sham procedure and at hours 0, 1, 2, 4, 8, 12,
24, 36, 48, 60, and 72 hours beginning immediately prior to the surgical
procedure. Cows were restrained using a halter or headlocks located within the
pen. The camera (Med2000TM, Meditherm, Inc. Fort Myers, FL) was positioned
approximately one-meter distance from the incision so that the entire incision and
paralumbar fossa was included in the image. Triplicate images were taken for
each time point and saved for future analysis. Using the accompanying software
(IRIS 7.5, WinTes II, Meditherm, Inc. Fort Myers, FL), the incision was isolated
from the image using the programs cropping function, and the maximum,
average, and minimum temperatures were recorded for each thermogram.

Statistical analysis
All statistical analyses were performed in Statistical Analyses System
(SAS Version 9.1: SAS Institute Inc., Cary NC; 1991-2001). The level of
significance was established to be P< 0.05.
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Normality test of the data and residuals was performed for each indicator.
MNT was normally distributed following log transformation then was analyzed
using the GLIMMIX procedure. All sites were averaged to give one reading per
time period to get the average reading. During the analysis, hours 0 and 1 were
removed from the time by treatment interaction. Animal ID and cranial site vs
caudal sites were used as a random effect. Surgeon and surgery block were
analyzed as random effect but had no significant effect and were removed from
the model. Fixed effects included treatment group. Time was used as a repeated
measure. Next, the three cranial sites and three caudal sites were divided,
averaged and analyzed. Tukey adjustment was used for MNT.
Maximum, mean and minimum temperatures for IRT were normally
distributed. Fixed effects included treatment group. Time was the repeated
measure. Animal ID was used as a random effect. Protected LSD was used for
adjustment. Surgeon and time of surgery (surgery block) was analyzed as a
random effect, but did not have a significant effect on any blood markers and was
therefore removed from the analysis.

Results
Two cows were removed from the study and not included in the results.
Cows included in the results is n = 22.
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Mechanical Nociceptive Threshold
All cattle demonstrated a time effect with a significantly higher tolerance of
pressure observed at 0 and 1 hr. following the surgical procedure (P < 0.001,
Figure 21). When the 0 and 1 hr. time points were excluded from the analysis in
an attempt to isolate responses that occurred without the influence of lidocaine,
the significance observed over time was removed (P = 0.24, Figure 22).
Numerically, cattle treated with meloxicam to demonstrate a higher tolerance of
pressure at 24- and 36-hours following surgery, but this effect was not significant
(P = 0.37). Location with respect to the incision on the MNT demonstrated a
significant difference, with the cranial sites requiring less force to elicit a
response (lower MNT) than the caudal sites (P = 0.03, Figure 23Figure ).
However, randomization of the start site had no effect on the overall MNT and
therefore was not included as a variable in the model.
Infrared Thermography
A significant time effect was observed for the maximum, average, and
minimum IRT observations for all animals (P< 0.001 for each corresponding
variable, Figure 24). There were no significant differences observed between
treatments or time by treatment interaction of the maximum skin surface
temperatures (P = 0.46 and 0.71 respectively, Figure 25). Cattle administered
meloxicam had slightly lower average and minimum surface temperatures at 2
hours following the surgery, but an overall treatment and time by treatment effect
was not observed (P = 0.91 and 0.67; P = 0.42 and 0.63, respectively, Figure 26
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and Figure 27). Table 1 displays the values for maximum, mean, and minimum
temperatures.

Discussion
In the present study, pressure algometry and IRT were used to evaluate
pain sensitivity and inflammation following an elective right flank laparotomy with
prophylactic omentopexy. Each technology successfully detected changes over
time compared to baseline observations. The administration of meloxicam
however, did not alter pain sensitivity or skin surface temperature sufficiently to
discriminate between treated and non-treated cattle.
In our study, the meloxicam treated cattle had significantly higher MNT
recordings than control cattle at baseline and 1-hour post-operative. This could
be the result of type 1 error, despite efforts to randomize cattle to groups. The
baseline measurements were taken prior to the administration meloxicam and
lidocaine and based on the reported pharmacokinetics of meloxicam, it’s doubtful
therapeutics concentrations were present at 1-hour post-administration. When
these time points were removed from the analysis, no significance was found at
all other clinically relevant time points. However, the time effect for all animals
does demonstrate that the surgical model created surgical and inflammatory pain
that was quantifiable using algometry.
Another finding in the present study was the differences observed
between sites cranial and caudal to the incision. We believe this is due to the
severing of the superficial innervation and loss of sensory input in the caudal
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area as the incision was made. Although innervation was not completely
removed as evidence by reduced MNT for all caudal measurements compared to
baseline, the fact that some sensation was removed is interesting and selection
of response sites should be considered carefully for future studies.
Several studies have evaluated MNT changes in cattle following
dehorning.(Allen et al., 2013; Heinrich et al., 2010; Stock et al., 2016; Tapper et
al., 2011) A common experimental design of these studies has been to collect
baseline observations prior to induction of the painful procedure, as has been
done here. In each of these studies, a significant reduction in MNT was observed
from baseline samples prior to dehorning compared to post-dehorning
observations. Another frequent design aspect is to maintain an independent
cohort that receives a sham procedure concurrently with animals receiving the
actual procedure. In the study presented here, the sham procedure was
conducted on the principal animals 2 weeks prior to initiation of the surgical
procedure. The advantages of this approach are the habituation of the animal to
sample collection and the direct comparison of results within the same animal.
Both approaches provide consistent application of the methodology and
comparison between affected and non-affected groups.
It appears that pressure algometry and MNT are most useful in the
presence of inflammation and active lesions. This bears true when the technique
has been applied to naturally occurring and experimentally induced lameness.
Whay et al. (1997) found a significant correlation between the severity of visually
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assessed lameness scores and pressure sensitivity in primiparous Holstein
heifers (Whay et al., 1997). Cutler et al (2013) demonstrated that digital
dermatitis lesions could be accurately identified by MNT as active, healing, or
healed lesions (Cutler et al., 2013). Likewise, Mohling et al. (2014) observed a
reduction of as much as 50% MNT in sows being subjected to chemically
induced lameness (Mohling et al., 2014). On the other hand, Wheeler et al (2013)
found that the probability of healthy calves to respond to pressure externally
applied to joints did not correlate with other indicators of inflammation and
therefore pressure algometry was not recommended for the assessment of
lameness in young calves (Wheeler et al., 2013).
Millman (2013) discusses the need to refine this technique by providing
proper restraint and blind folding calves to avoid anticipation and fear-based
responses. This would lead to more reliable testing for both intraobserver and
interobserver measurements. Raundal et al. found a high level of individual
animal variation and low agreement of MNT readings between observers
(Raundal et al., 2014). Tallant et al., found dogs became accustomed to
algometry and tolerance varied by position and observer (Tallant et al., 2016).
Blindfolding was not performed in the current study and the only attempt to
acclimate and normalize responses was the placement of the observer’s hand
near the incision. Perhaps had additional efforts been used to remove the
anticipatory effects of the approaching observer, greater differences among the
treatment groups would have been observed.
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Changes in the maximum, mean and minimum skin surface temperatures
at the surgical site were observed over time for both treatments, suggesting the
successful induction of physiologic mechanisms that influence these
temperatures. Maximum and mean temperatures increased from baseline and
remained elevated throughout, while the minimum temperatures decreased from
the time of surgery. This was likely the result of post-operative inflammation and
was an expected response as has been described with IRT mapping of surgical
wounds (Celeste et al., 2013).
The administration of meloxicam did not appear to alter the inflammatory
process at the level of the incision sufficiently to induce detectable differences in
skin temperature. However, there was a numerical trend for treated cows to have
lower mean and minimum skin temperatures at 2 hours. In most recent studies,
utilizing IRT in cattle, the technique is more often used to monitor periocular
temperature and systemic autonomic responses to painful conditions (Coetzee et
al., 2012; Schaefer et al., 2012; Stewart et al., 2009; Stewart et al., 2010). In
many of these studies, NSAID therapy has reduced periocular temperature and
stabilized the autonomic or stress induced response. In the current study,
periorbital temperature was not recorded and the impact of the changes in the
autonomic nervous system on skin temperatures at the surgical site is unknown,
but presumably has limited effect.
An unexpected observation made during the analysis of the thermograms
revealed a spurious assignment of low temperatures associated with the suture
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material in each incision. Each surgeon left an irregular length of suture tag,
where longer tags had an influence on the range and minimum surface
temperatures assigned in the region of interest, which could not be excluded.
However, these variations as well as other animal independent differences were
accounted for in the statistical model during final analysis.
To our knowledge, this is the first study to evaluate the efficacy of
meloxicam as post-operative pain management for cattle following a simulated
surgical DA repair. Barrier et al. (2014) evaluated beef cattle undergoing
cesarean section and found that meloxicam treated cattle had greater lying times
in the first 16 hours after delivery. An additional head to head to clinical trial
comparing meloxicam and ketoprofen in cattle after rumen fistulation surgery,
found evidence of pain after surgery, but no differences between treatments.
These studies suggest a limited efficacy of meloxicam in soft tissue surgery, but
this appears to be in stark contrast to studies evaluating its efficacy in other
painful conditions. For example, multiple studies have revealed a benefit from
meloxicam treatment in reducing stress and inflammatory biomarkers, improving
pressure tolerance and MNT, and improving behavioral responses of cattle
undergoing cautery dehorning, castration, mastitis and transportation. Therefore,
care should be used when drawing the conclusion that meloxicam therapy is
ineffective for pain mitigation associated soft tissue surgery.
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Conclusions
Although a difference between treatment groups was not detected, MNT
and IRT are promising noninvasive technologies for inflammatory pain detection.
These technologies would be ideal for monitoring pain sensitivity and
inflammation following surgical interventions and would be useful in assisting
veterinarians and producers in making decision about pain management.
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Conclusions
Approximately 470,000 cows undergoing painful surgical procedures
every year, producers and veterinarians are seeing the effects of pain first hand.
Objective measurements are need to quantify this pain as well as a model to
research this pain and analgesic methods.
This study presents several possible methods of measuring pain including
blood parameters and non-invasive objective technology. The blood biomarkers
that demonstrated the highest degree of difference in meloxicam treated cattle
compared to placebo-treated control cattle were PGE2, haptoglobin, and cortisol.
Cows that received meloxicam had significantly lower PGE2 levels at 2 and 8
hours after surgery (P= 0.0044 and P=0.0001, respectively), significantly lower
haptoglobin levels are 72 and 96 hours after surgery (P = 0.0153 and 0.0002,
respectively), and significantly lower cortisol levels at 4 hours after surgery (P <
0.0001) than placebo-treated controls. Although fibrinogen showed no significant
difference between the groups, fibrinogen concentration did show a time effect (P
< 0.0001), though these changes never increased over a clinically relevant
threshold.
This study also evaluated mechanical nociceptive threshold and infrared
thermography. MNT measurements in cattle treated with meloxicam trended to
demonstrate a higher tolerance of pressure at 24- and 36-hours following
surgery, but this effect was not significant (P = 0.3710). Cattle administered
meloxicam had slightly lower mean and minimum skin surface temperatures at 2
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hours following the surgery, but an overall treatment and time by treatment effect
was not observed (P = 0.9144 and 0.6736; P = 0.4186 and 0.6277, respectively).
While these non-invasive methods did not detect a difference between the
treatment groups, it did detect a change in the post-operative period, confirming
that this surgical model does in fact create inflammation and pain that is
quantifiable. These observations are consistent with the routine inclusion of these
technologies in other pain studies and underscores the relevance of their use in
pain studies in cattle.
This study demonstrates meloxicam provides analgesia for dairy cattle
undergoing soft tissue surgery. Moreover, this study demonstrates that cattle
experience pain and should be provided multi-modal analgesia for painful
procedures. As responsible advocates of agriculture and animal welfare, it is the
animal agriculture community’s duty to see that these animals are treated
appropriately. We should be at the forefront of these issue and determining the
best way to provide the best well-being to these animals based on sound
scientific research.
More research is needed to advance pain management for cattle.
Because these animals are stoic and difficult to assess pain in, new and
innovative methods of detecting pain are needed. This study has found methods,
both blood parameters and technologies, that address this issue. More of these
techniques are needed to further improve our ability to assess pain. It also
demonstrates using a unique surgical model to create and then assess pain in
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dairy cattle. Finally, from this study, not only have we provided a number of
assessment tools of pain, but have also confirmed the use of meloxicam as an
analgesia. There is a major need for research to prove that not only meloxicam,
but other analgesic methods are not only useful tools but warranted measures
both as a single modality or in a multi-modal approach.
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Figure 1 – Sham PGE2 concentrations by treatment group
PGE2 concentration for control cattle (shaded) and meloxicam treated cattle
(solid) were significantly different between the treatment groups during the sham
prodecure (P = 0.02).
60

PGE2 pg/mL

50
40
30
20
10
0
0

2

4

8

12 24 48 72 96 120 144 168

Hours After Sham

Figure 2 – Sham PGE2 concentrations over time in all cattle
PGE2 concentrations were determined at each time point for all cattle over time
during the sham phase. Data represent the mean for all cattle over time. PGE
was affected by time (P < 0.001).
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Figure 3 – Surgical PGE2 concentrations in
meloxicam and placebo-treated cattle
Least square means PGE2 concentrations in
placebo-treated cows (dash line and □) and
meloxicam-treated cows (solid line and ●) over
time after an elective laparotomy with
prophylactic omentopexy. A time by treatment
interaction was observed (P = 0.003). Control
cows had significantly higher PGE2 levels at 2
and 8 hours after surgery than meloxicam
cows (P = 0.004 and P < 0.001, respectively).
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Figure 4 – Sham total cortisol over time for all cattle
Total cortisol concentrations were determined at each time point during the sham
procedure. Data represent the LS mean for all cattle over time. There was a
significant difference over time (P = 0.015)
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Figure 5 – Sham CBG concentration over time for all cattle
CBG concentration was determined at each time point during the sham
procedure. Data represent the LS mean for all cattle over time. There was a
significant difference in time points (P > 0.001).
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Figure 6 – Surgical cortisol concentration
in meloxicam and placebo treated cattle
LS means of cortisol (ng/mL) in placebotreated cows (dash line and □) and
meloxicam-treated cows (solid line and ●)
over time after an elective laparotomy with
prophylactic omentopexy. Control cows had
significantly higher cortisol concentrations
than meloxicam cows at 4 hours after
surgery (P < 0.001).
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Figure 7 –Surgical Cortisol Binding
Globulin concentration in all cattle over
time
LS means of CBG for all animals over time
following elective laparotomy with prophylactic
omentopexy. CBG was affected by time (P >
0.0001) but not by treatment group or time by
treatment interaction (P = 0.1396 and P =
0.5187, respectively).
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Figure 8 – Surgical Cortisol Binding
Globulin (CBG) in meloxicam and placebo
treated cattle
LS means of CBG (mg/L) in placebo-treated
cows (dash line and □) and meloxicamtreated cows (solid line and ●) over time
after an elective laparotomy with prophylactic
omentopexy. CBG was affected by time, but
there was not difference observed between
treatment or time by treatment interaction (P
= 0.14 and P = 0.52, respectively)
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Figure 9 – Free cortisol index (FCI) for all cattle
following elective laparotomy
LS means of FCI over time after elective laparotomy with
prophylactic omentopexy. FCI was affected by time (P <
0.001), but not by treatment or time by treatment
interaction (P = 0.34 and P = 0.29, respectively).

109

120

100

FCI (nmol/mg)

80

60

40

20

0
0

2

4

8

12

24

36

48

60

72

Hours after surgery

Figure 10 – Free Cortisol Index in meloxicam and placebotreated cattle over time
LS means of FCI (nmol/mg) in placebo-treated cows (dash line
and □) and meloxicam-treated cows (solid line and ●) over time
after an elective laparotomy with prophylactic omentopexy. FCI
was affected by time, but there was not difference observed
between treatment or time by treatment interaction (P = 0.34 and
P = 0.29, respectively)
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Figure 11 – Sham Fibrinogen concentration in all cattle over time
Fibrinogen concentration (mg/dL) in all cattle over time for all cattle showed a
significant time effect (P > 0.001) but did not show a treatment (P = 0.52) or time
by treatment interaction (P = 0.96).
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Figure 12 – Surgical Fibrinogen
concentration in all cattle over time
LS means of fibrinogen for all animals over time
after elective laparotomy with prophylactic
omentopexy. A time effect was seen in response
to the time of surgery (P < 0.001).
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Figure 13 – Surgical Fibrinogen
concentrations in meloxicam and placebotreated cattle
LS means fibrinogen concentration in placebotreated cows (dash line and □) and meloxicamtreated cows (solid line and ●) over time after an
elective laparotomy with prophylactic
omentopexy. Treatment groups did not differ (P
= 0.56) nor was a time by treatment interaction
observed (P = 0.43).
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Figure 14 – Sham Haptoglobin concentrations over time for all cattle
Haptoglobin concentration slowly increased after the first 24 hours during the
sham procedure over time for all cows (P = 0.0019).
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Figure 15 – Sham Haptoglobin and Matrix Metalloproteinase 9 complex
concentration in all cattle over time
Hp and MMP 9 complexes displayed spikes at 24 hr. and 120 hr. after sham
procedure with an overall a significant time effect (P > 0.0001).
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Figure 16 – Surgical Haptoglobin
concentration in meloxicam and placebotreated cattle
LS means haptoglobin concentration in placebotreated cows (dash line and □) and meloxicamtreated cows (solid line and ●) over time after an
elective laparotomy with prophylactic
omentopexy. CON had significantly higher Hp
concentrations (mcg/mL) at 72 and 96 hours
after surgery (P = 0.0153 and 0.0002,
respectively).
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Figure 17– Surgical Haptoglobin and Matrix
Metalloproteinase 9 complex concentration in meloxicam
and placebo-treated cattle
LS means of Hp-MMP 9 complex concentration in placebotreated cows (dash line and □) and meloxicam-treated cows
(solid line and ●) over time after an elective laparotomy with
prophylactic omentopexy. A time effect and a time by treatment
interaction was found (P < 0.0001 and P = 0.0107, respectively)
but no treatment effect was observed (P = 0.5317). Contol cows
had a significantly lower Hp-MMP 9 complex concentration at 72
hours post surgery.
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Figure 18 – Surgical Matrix Metalloproteinase concentration in all
cattle over time
LS means of Hp-MMP 9 complex concentrations in all cows over time
after elective laparotomy with prophylactic omentopexy. A significant
time effect was observed (P < 0.0001). Hours 8, 12, 24, and 48 were
significantly higher in all cows after surgery.

Figure 19 - FD/S-3 conical
steel tip used for MNT
measurements.
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Figure 100 - Example of algometry sites
around the incision. Sites 1, 2, and 3 are
cranial sites and 4, 5, and 6 are caudal sites.
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Figure 21 – Mechanical nociceptive threshold following a right
flank laparotomy and prophylactic omentopexy (including
times 0 and 1 hour)
There was a significant time effect observed with hours 0 and 1
being significantly higher than all other hours (P < 0.001). Prior to
the surgical procedure, lidocaine was used to induce local
anesthesia. The significant decrease in the pain threshold at hour 2
demonstrates the change in sensitivity to pressure due to
inflammation and surgical pain without the influence of lidocaine.
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Figure 22 - Mechanical nociceptive threshold following a right
flank laparotomy and prophylactic omentopexy in cattle treated
with meloxicam or placebo (excluding times 0 and 1 hour)
There was no significant difference between treatment groups
(MEL; solid line with circles, CON; dashed line with open squares, P
= 0.37). No time by treatment interaction was observed (P = 0.24)
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Figure 23 - Combined mean MNT for all cranial and caudal test sites
for all cattle
There was a significant difference between the cranial and caudal
readings across all cows with the cranial sites requiring less force to elicit
a response (lower MNT) than the caudal sites (P = 0.031).
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Figure 24 – Maximum, Mean, and Minimum skin surface temperatures
collected by infrared thermography on all animals over time
Maximum (dashed with squares), mean (solid with circles), and minimum
(dotted with diamonds) temperatures displayed a significant time effect
(P<0.001, for each variable).
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Figure 25 - Maximum skin surface temperatures collected by infrared
thermography following a right flank laparotomy and prophylactic
omentopexy in cattle treated with meloxicam or placebo.
The least square mean of the maximum IRT temperatures were affected by
time (P< 0.0001), but showed no significant difference between treatment
and time by treatment interaction (P = 0.46 and 0.71 respectively).
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Figure 26 - Mean skin surface temperatures collected by infrared
thermography following a right flank laparotomy and prophylactic
omentopexy in cattle treated with meloxicam or placebo.
The least square mean of the mean surface temperatures was affected by time
(P < 0.001), but showed no significant difference between treatment and time
by treatment interaction (P = 0.91 and 0.67 respectively).
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Figure 27 - Minimum skin surface temperatures collected by infrared
thermography following a right flank laparotomy and prophylactic
omentopexy in cattle treated with meloxicam or placebo.

The least square mean of the minimum IRT temperatures were affected by
time (P < 0.0001), but showed no significant difference between treatment
and time by treatment interaction (P = 0.42 and 0.63 respectively).
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Table 1 – Maximum, Mean and Minimum skin surface temperature within 72 hours of elective right flank
laparotomy with prophylactic omentopexy
a-d represent significant differences between LS means of temperature within columns over time for all cows

Hours
After
Surgery
0
2
4
8
12
24
36
48
60
72

Maximum Temperatures
LS Mean of
Standard
Temperature
Error
32.3619 a
31.3499 cd
31.2245 d
31.5420 bcd
31.1350 d
31.2822 d
32.1091 abc
32.2800 ab
31.1001 d
31.5238 abcd

0.3037
0.3037
0.3037
0.3037
0.3037
0.3037
0.3111
0.3037
0.3037
0.3331

Average Temperatures
LS Mean of
Standard
Temperature
Error
33.7420 d
34.9772 bc
34.7308 c
34.9952 bc
34.8856 c
34.8861 c
35.5564 a
35.4355 ab
34.8668 c
34.9008 bc

0.1928
0.1928
0.1928
0.1928
0.1928
0.1928
0.1974
0.1928
0.1928
0.2113

Minimum Temperatures
LS Mean of
Standard
Temperature
Error
32.3619 a
31.3499 cd
31.2245 d
31.5420 bcd
31.1350 d
31.2822 d
32.1091 abc
32.2800 ab
31.1001 d
31.5238 abcd

0.3037
0.3037
0.3037
0.3037
0.3037
0.3037
0.3111
0.3037
0.3037
0.3331
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